Schizophrenia occurs worldwide and is among the most severe mental disorders. Its aetiology remains unknown, although both genetic and environmental risk factors are known to be involved. Its pathophysiology is also largely obscure, and consequently the available treatment can alleviate symptoms but not cure the disease. The enormous psychological and social distress schizophrenia causes and the limited means available for helping its sufferers means that its aetiology and pathophysiology are among the most extensively studied of the mental disorders. (Schultz & Andreasen 1999)
Schizophrenia appears to be more prevalent in Finland than in most other western countries (Torrey 1987, Lehtinen et al 1990, Hovatta et al 1997), and is a leading cause of disability retirement there, particularly among the population aged 16 to 44 years (KELA 1996). "The Genetic Epidemiology and Molecular Genetics of Schizophrenia in Finland" project, initiated in 1988, is a collaborative venture of the Department of Mental Health and Alcohol Research and the Department of Human Molecular Genetics of the National Public Health Institute. The aim of the project is to identify genetic and environmental factors predisposing to schizophrenia. The current thesis forms part of that project.
The disease entity nowadays called schizophrenia was first delineated by Emil Kraepelin (1856-1926) in 1893 (Harms 1971). Kraepelin used the name dementia praecox for the disease to stress its early onset and the permanent deterioration of mental functioning it causes among the great majority of patients. He defined dementia praecox as "a series of states, the common characteristic of which is a peculiar destruction of the internal connections of the psychic personality. The effects of this injury predominate in the emotional and volitional spheres of mental life". (Kraepelin 1919, p. 3).
Kraepelin detailed the symptoms commonly occurring in schizophrenia (Table 1), the most fundamental features of which were the weakening of volition and emotional dullness, which cause mental activities to decline, and the loss of inner unity of the activities of intellect, emotion and volition, which causes incoherence in thinking and action and inappropriate affect. However, he considered no symptom as pathognomonic for schizophrenia. (Kraepelin 1919, pp. 11-73 and 257)
Originally, Kraepelin divided dementia praecox into three clinical subtypes: hebephrenic, catatonic, and paranoid. He later elaborated this subtyping to include several other categories, while emphasizing that the subgrouping of different clinical pictures was rather artificial and of limited clinical value. (Kraepelin 1919, pp. 89-180)
Kraepelin was also the first to formulate the concept of manic-depressive insanity. In distinguishing this from dementia praecox, he did not consider any single symptom as characteristic of either disease, but stressed the importance of evaluating the whole clinical picture. The symptoms suggestive of dementia praecox in the presence of affective symptoms were lack of inner logical arrangement of mental events, early appearance of numerous auditory hallucinations, bizarre delusions, delusions of influence on will, and incoherent speech. Symptoms more suggestive of manic-depressive illness were a tendency to, and ability for, observation of self, and periodic course with complete restoration of psychic and social functioning in between. Disorders characterized by delusions and hallucinations in which disorders of emotion and volition did not exist or were minimal were referred to by Kraepelin as paraphrenias. Although these had many features in common with the paranoid form of dementia praecox, Kraepelin considered that the well-preserved mental activities and absence of disorders of volition justified the classification of paraphrenias into a separate disease entity. (Kraepelin 1919, pp. 260-328)
Table 1. Symptoms of dementia praecox according to Kraepelin
A. Auditory hallucinations
B. Tactile hallucinations
C. Hallucinations of smell and taste
3. Incoherence of thought and speech
4. Catatonic symptoms
5. Disordered attention
6. Disordered judgement
7. Emotional dullness
Unlike Kraepelin, Eugen Bleuler (1857-1939) did not emphasize poor outcome in diagnosing schizophrenia. It had also become more evident since Kraepelin introduced the concept of dementia praecox that the disorder did not always begin in adolescence or early adulthood. Thus, Bleuler suggested that the name of the disease be changed to "schizophrenia" because of the characteristic disintegration of various mental functions. (Bleuler 1911, pp. 7-8)
Bleuler divided symptoms of schizophrenia into fundamental symptoms, which he considered as characteristic of schizophrenia and present in every patient and at every period of the disease, and accessory symptoms, which may dominate the clinical picture but may also be completely absent and are not pathognomonic for schizophrenia (Bleuler 1911, p. 13). The fundamental symptoms (Table 2) were disturbances of association, affectivity and attention, ambivalence, and autism. Bleuler also regarded the absence of primary disturbances of perception, orientation and memory as fundamental to schizophrenia. Some other features of the disease, such as lack of will, disturbed behaviour, and disorders in intelligence, were considered to be a consequence of these fundamental symptoms. The severity of the fundamental symptoms in individual patients may vary from "a maximum which corresponds to complete confusion to a minimum which may be hardly noticeable". Bleuler regarded delusions, hallucinations, and catatonic symptoms as accessory symptoms, although he admitted that it is often because of them that patients come to psychiatric treatment. (Bleuler 1911, pp. 14-226)
The diagnosis of schizophrenia was based on the presence of fundamental symptoms, though not all of them needed to be apparent in a given patient. The duration of symptoms and the outcome of the illness were not emphasized in diagnosing the disorder. Although Bleuler did not consider outcome important, he stated that "As yet I have never released a schizophrenic in whom I could not still see distinct signs of the illness; indeed there are very few in whom one would have to search for such signs." (Bleuler 1911, p. 256)
Bleuler divided schizophrenia into four subgroups: paranoid, catatonic, hebephrenic and simple type. Paranoid type was characterized by the presence of prominent delusions and hallucinations and included, besides paranoid forms of dementia praecox, the majority of patients Kraepelin would have diagnosed as suffering from paraphrenia. Various catatonic symptoms dominated the clinical picture in the catatonic type. Hebephrenic type consisted of all the other patients who had, at some point in their illness, exhibited acute psychotic symptoms and subsequently deteriorated but who did not present with paranoid or catatonic characteristics. Simple schizophrenia consisted of patients who gradually deteriorate affectively and intellectually without exhibiting other prominent symptoms. (Bleuler 1911, pp. 227-238)
Table 2. Fundamental symptoms of schizophrenia according to Bleuler
Kurt Schneider (1887-1967) aimed at identifying signs and symptoms that would be highly discriminating for schizophrenia and would be easily perceived by the treating physician (Carpenter et al 1973, Andreasen & Carpenter 1993). The symptoms he chose as characteristic of schizophrenia were quite different from the fundamental symptoms of Bleuler. He identified a group of delusions and hallucinations which he believed to be pathognomonic for schizophrenia and called these symptoms "first-rank symptoms" (Table 3) (Carpenter et al 1973). Other symptoms which occurred frequently in schizophrenia but were not pathognomonic for it were called second-rank symptoms. Schneider's diagnostic concept of schizophrenia has had considerable influence on almost all diagnostic systems subsequently developed.
Table 3. First-rank symptoms of schizophrenia according to Schneider
(Carpenter et al 1973)
The International Classification of Diseases is a disease classification system developed by the World Health Organization to promote international comparability of health care statistics. The eighth revision of the International Classification of Diseases (ICD-8), launched in 1967, placed considerable emphasis on Schneiderian first-rank symptoms in its description of schizophrenia (WHO 1967). It included seven subtypes of schizophrenia. The simple type was characterized by oddities of conduct, difficulties in social relationships, and decline in overall performance but without clear-cut symptoms of schizophrenia. Typical symptoms of the hebephrenic type were inappropriate affect, bizarre or catatonic behaviour, and prominent thought disorder. The catatonic type was characterized by catatonic symptoms, and the paranoid type by prominent delusions and hallucinations. In the acute schizophrenic episode, the onset of schizophrenic symptoms was acute, and a dream-like state with slight clouding of consciousness and perplexity was often present. The latent type was characterized by the emergence of symptoms not obviously schizophrenic but severe enough to raise a strong suspicion of schizophrenia. The residual type was reserved for chronic residual states in which fragments of faded schizophrenic symptomatology occurred. In addition, "other" and "unspecified" types were reserved for patients that did not fit into other subtypes. Infantile autism was regarded as a part of schizophrenia. (WHO 1967, General Register Office 1968)
The second edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-II), published in 1968, gave a Bleulerian definition of schizophrenia, broader than the ICD-8 definition. According to DSM-II, the mental state in schizophrenia was primarily attributable to a thought disorder, which may lead to misinterpretation of reality and sometimes to delusions and hallucinations.The subtyping of schizophrenia was similar to ICD-8, except that an eighth, childhood type, was included. (APA 1968)
The Washington University or St. Louis or Feighner Criteria, published in 1972, represented the first diagnostic classification validated primarily by follow-up and family studies, rather than by clinical judgement and experience (Feighner et al 1972). Feighner Criteria were also the first to assign operational diagnostic criteria to each disorder they include. The diagnostic criteria for schizophrenia emphasized poor premorbid functioning, chronicity of the disorder, and absence of affective symptoms (Table 4). Subtyping was not included. Of the commonly used diagnostic criteria for schizophrenia, Feighner's criteria are the most restrictive (Hill 1996, McGorry 1992).
Table 4. The Washington University Criteria (Feighner Criteria) for schizophrenia
For a diagnosis of schizophrenia, A through C are required:
A. Both of the following are necessary:
B. The patient must have at least one of the following:
C. At least three of the following manifestations must be present for a diagnosis of "definite" schizophrenia, and two for a diagnosis of "probable" schizophrenia.
(Feighner et al 1972)
Patients who fulfill the diagnostic criteria for primary affective disorder but in addition have "a massive or peculiar alteration of perception and thinking as a major manifestation of their illness" do not have any diagnostic class in Feighner classification but are classified as having an undiagnosed psychiatric disorder.
The Research Diagnostic Criteria (RDC), introduced in 1975, were modified and expanded from the Feighner Criteria. The diagnostic criteria of schizophrenia, however, changed significantly. The requirement of illness duration shortened from 6 months to 2 weeks. Schneider's first rank symptoms were given considerable weight in the diagnosis, while social and occupational functioning, age at onset, and family history lost their significance (Table 5). (Spitzer et al 1978)
Table 5. Research Diagnostic Criteria for schizophrenia
A. During an active phase of the illness at least two of the following are required for definite and one for probable diagnosis of schizophrenia:
RDC included five subtypes of schizophrenia. Prominent symptoms of each type were: delusions and/or hallucinations in the paranoid type, marked formal thought disorder and inappropriate or blunted affect or not well-organized delusions or hallucinations in the disorganized type, and catatonic symptoms in the catatonic type. The undifferentiated type was reserved for periods of illness that met the criteria for more than one subtype or none of them, and the residual type was used when psychotic symptoms were no longer prominent but residual symptoms prevailed. The mood disorder exclusion criteria remained as strict as in the Feighner criteria. For those patients that met the criteria for a manic or depressive syndrome but in addition had at least one symptom indicative of schizophrenia, a new diagnostic class, schizoaffective disorder, emerged. Schizoaffective disorder was a broad class, including forms in which schizophrenic symptoms were of brief duration compared with the duration of affective symptoms, or vice versa. It required the presence of only one symptom suggestive of schizophrenia. This very broad definition of schizoaffective disorder was constructed to help researchers "purify" samples of patients with schizophrenia or affective disorder by separating out those presenting mixed symptomatology. (Spitzer et al 1978)
In the ninth edition of the International Classification of Diseases, published in 1977 (WHO 1977), the description of schizophrenia had hardly changed from ICD-8. However, childhood type schizophrenia and infantile autism were removed from schizophrenic psychoses. Simple and latent schizophrenia remained in the classification, but their use was discouraged (WHO 1978).
After five years of development and field trials involving over 800 clinicians, DSM-III was launched in 1980. DSM-III differed from previous internationally used diagnostic classifications such as DSM-II and ICD-9 in that operational diagnostic criteria were provided for each disorder, and from RDC and Feighner criteria in that all diagnostic classes were included. (Spitzer et al 1980)
The diagnostic criteria for schizophrenia in DSM-III were a mixture of Feighner and RDC criteria (Table 6). As in Feighner criteria, a 6-month duration of symptoms and deterioration from a premorbid level of functioning were required. However, Schneiderian first-rank symptoms were given considerable weight, as in the RDC criteria. The concept of schizophrenia was narrower than that applied in the DSM-II and ICD-9. DSM-II and ICD-9 diagnoses of simple and latent type were omitted and would usually correspond to a severe form of schizotypal or borderline personality disorder in DSM-III. Some individuals diagnosed with schizophrenia in DSM-II and ICD-9 because of the concurrence of Schneiderian first-rank symptoms with symptoms of major affective disorder would be diagnosed as suffering from an affective disorder in DSM-III. DSM-III provided an explicit age-at-onset criterion: the onset of at least prodromal symptoms must occur before 45 years. The subtypes of schizophrenia were identical to those used in RDC: disorganized, catatonic, paranoid, undifferentiated, and residual. A diagnosis of schizophreniform disorder was given when all other diagnostic criteria for schizophrenia except the duration were fulfilled. Schizoaffective disorder was the only diagnosis in DSM-III for which diagnostic criteria were not provided, because a consensus committee found it impossible to agree on the criteria. (APA 1980, Spitzer et al 1980, Skodol & Spitzer 1982, Williams & Spitzer 1982)
The diagnostic criteria for schizophrenia in the revised version of DSM-III (DSM-III-R), launched in 1987, changed in a few noteworthy ways. Most obviously, the age at onset criterion was omitted. A time duration of at least one week, or less if successfully treated, was set for the acute phase symptoms. First-rank symptoms were slightly less significant than in DSM-III. A criterion for schizophrenia in the presence of autistic disorder was added. More explicit mood and schizoaffective disorder exclusion criteria were given, because DSM-III-R included diagnostic criteria for schizoaffective disorder. The subtyping of schizophrenia remained identical to that used in DSM-III. (APA 1987)
Table 6. DSM-III criteria for schizophrenia
A. At least one of the following during a phase of the illness:
The tenth edition of the International Classification of Diseases (ICD-10) was published in 1992. It is the first ICD edition to provide operationalized diagnostic criteria for research purposes. It is therefore more meaningful to compare the criteria for schizophrenia (Table 7) with DSM-III-R criteria than with the previous ICD versions.
Table 7. ICD-10 Diagnostic Criteria for Research for schizophrenia
I. Either at least one of the syndromes, symptoms, and signs listed under 1. below, or at least two of the symptoms and signs listed under 2. should be present for most of the time during an episode of psychotic illness lasting for at least 1 month (or at some time during most of the days):
II. Exclusion clauses:
The required duration of symptoms is considerably shorter in ICD-10 than in DSM-III-R, one vs. six months, and ICD-10 does not require deterioration from a premorbid level of functioning. The mood disorder exclusion criterion in ICD-10 requires that the onset of psychotic symptoms must have preceded the onset of mood symptoms, while DSM-III-R requires that the total duration of all episodes of a mood syndrome has been brief relative to the total duration of the active and residual phases of the disturbance. ICD-10 gives considerable weight to Schneiderian first-rank symptoms, but is also the first diagnostic classification to include negative symptoms. ICD-10 includes the DSM-III-R subtypes, paranoid, disorganized, catatonic, undifferentiated, and residual. In addition, simple schizophrenia is retained from ICD-9. (WHO 1993)
The fourth edition of the Diagnostic and Statistical Manual for Mental Disorders was published in 1994. The largest difference between DSM-III-R and DSM-IV criteria (Table 8) for schizophrenia is in the description of characteristic symptomatology. The criterion for duration of acute phase symptoms is extended from one week to one month. Hallucinations are no longer required to be prominent. DSM-IV uses the term "disorganized speech" instead of "incoherence or marked loosening of associations" for schizophrenic thought disorder. Besides catatonic symptoms, grossly disorganized behaviour is included as a symptom criterion. Negative symptoms are included in the criteria for the first time in the DSM system. (APA 1994)
The subtype names are identical to those used in DSM-III-R, but a hierarchy is given for them. Catatonic type is assigned whenever prominent catatonic symptoms are present regardless of other symptoms. If the criteria for catatonic type are not fulfilled, the disorganized type is assigned whenever disorganized speech and behaviour, and flat or inappropriate affect are present. If the criteria for neither catatonic nor disorganized type are present, the paranoid type is assigned whenever there is a preoccupation with delusions or frequent hallucinations. If there are prominent active-phase symptoms and the criteria for catatonic, disorganized, or paranoid type are not fulfilled, the undifferentiated type is assigned. The residual type is used when active-phase symptoms are no longer present but there is continuing evidence for the disturbance. (APA 1994)
Table 8. DSM-IV Diagnostic Criteria for schizophrenia
A. Characteristic symptoms: Two or more of the following, each present for a significant portion of time during a 1-month period (or less if successfully treated):
B. Social/occupational dysfunction: for a significant portion of the time since the onset of the disturbance, one or more major areas of functioning such as work, interpersonal relations, or self-care are markedly below the level achieved prior to the onset (or, when the onset is in childhood or adolescence, failure to achieve the expected level).
C. Duration: Continuous signs of the disturbance persist for at least 6 months, of which at least one month should be of symptoms that meet Criterion A. The 6 months may include periods of prodromal and residual symptoms.
D. Schizoaffective and mood disorder exclusion: Schizoaffective disorder and mood disorder with psychotic features have been ruled out because either no major depressive, manic, or mixed episodes have occurred concurrently with the active-phase symptoms, or if mood episodes have occurred during active-phase symptoms, their total duration has been brief relative to the active and residual periods.
E. Substance/general medical condition exclusion: The disturbance is not due to the direct physiological effects of a substance or a general medical condition.
F. Relationship to a pervasive developmental disorder: if there is a history of autistic disorder or another pervasive developmental disorder, the additional diagnosis of schizophrenia is made only if prominent delusions or hallucinations are also present for at least a month (or less if successfully treated).
During the 20th century, psychiatric nosology has evolved from "the great professor principle" through "the consensus of experts" to a scientific psychiatric nosology (Kendler 1990). The diagnostic concepts of schizophrenia of Kraepelin, Bleuler, and Schneider followed the great professor principle. While the detailed descriptions of symptoms in schizophrenia given by Kraepelin and Bleuler were quite similar, both men came to regard totally different aspects of the disorder as essential: while Kraepelin stressed chronicity and poor outcome, Bleuler stressed the presence of fundamental symptoms of disordered association, attention, and affectivity, plus autism and ambivalence (Kraepelin 1919, Bleuler 1911). Both described the hallucinations and delusions later termed first-rank symptoms by Schneider, but neither regarded them as essential features of schizophrenia (Kraepelin 1919, Bleuler 1911). Thus, by analogy, in trying to define the essentials of an elephant, Kraepelin chose "trunk", Bleuler "ears", and Schneider "feet".
DSM classifications prior to DSM-III, and ICD classifications prior to ICD-10, relied on the consensus of experts principle. In the 1960s this consensus was quite different in Europe and the United States. Thus, DSM-II adopted a broad Bleulerian definition of schizophrenia, while ICD-8 descriptions focused on Schneiderian first-rank symptoms. When comparisons of diagnostic concepts in the United Kingdom and United States were conducted in the 1960s and 1970s, it became evident that American psychiatrists diagnosed schizophrenia much more often than their British counterparts, who were more likely to diagnose affective disorders (Leff 1977). Psychiatrists in Nordic countries also applied a narrow definition of schizophrenia (Leff 1977). The large variation in diagnostic practices promoted the development of scientific nosology in psychiatry (Kendler 1990). Since Feighner's criteria, available scientific knowledge has been used to develop diagnostic criteria. European psychiatrists have trailed behind their American colleagues in this development, ICD-10 being the first European classification to provide operational diagnostic criteria.
Scientific nosology aims at maximizing the reliability and validity of diagnostic concepts. Criteria are reliable if diagnosticians in different countries reproduce the same diagnosis from the same patients. The validity of a diagnostic concept is a much more complex matter. It is usually tested by using external validators, such as family history, biological and psychological tests, treatment response, diagnostic stability, and course of illness. However, different validators often fail to agree. For example, DSM-III criteria for schizophrenia define a patient population with a relatively poor outcome, but if family history were to be included as a validator, broader criteria for schizophrenia should be applied. A consensus of experts usually decides which validator should be given the highest priority, which has led to differences between diagnostic systems. (Kendler 1990)
The most often used diagnostic criteria in clinical practice and research nowadays are DSM-IV, ICD-10, RDC, and Feighner criteria. Although the definitions of schizophrenia in different diagnostic systems converge to a large extent, there are differences (Table 9). All except Feighner criteria give considerable weight to Schneider's first rank symptoms, although DSM-IV less so than RDC and ICD-10. The required duration of symptoms is variable, ranging from 2 weeks in RDC to 6 months in DSM -IV and Feighner criteria. The boundaries of schizophrenia, schizoaffective disorder and psychotic affective disorder are highly variable. Feighner and DSM-IV criteria follow the Kraepelinian tradition of stressing poor outcome, while such a criterion has not been included in RDC and ICD-10. The agreements between the systems in terms of clinical diagnoses are not impressive. In one study, the concordances for schizophrenia measured by kappa values (Shrout et al 1987) were 0.67 for DSM-III vs. RDC, 0.57 for DSM-III vs. Feighner criteria, and 0.44 for RDC vs. Feighner criteria (McGorry et al 1992). In another study, they were 0.64 for DSM-III-R vs. RDC, 0.59 for DSM-III-R vs. ICD-10, 0.58 for DSM-III-R vs. Feighner criteria, and 0.71 for ICD-10 vs. RDC (Hill et al 1996).
The considerable weighting of Schneider's first rank symptoms in several diagnostic systems is particularly problematic. Several studies have shown that they are not pathognomonic for schizophrenia (Carpenter et al 1973, Peralta & Cuesta, 1999). Carpenter et al found them in 51% of patients with DSM-II schizophrenia and in 23% of patients with DSM-II affective psychoses (Carpenter et al 1973). Peralta and Cuesta found them in 69% of patients with schizophrenia, 83% with schizophreniform disorder, 65% with schizoaffective disorder, 43% with mood disorder, 52% with brief reactive psychotic disorder, and 48% of patients with psychotic disorder not otherwise specified, in a study that used DSM-III-R criteria (Peralta & Cuesta 1999). Having first-rank symptoms did not significantly increase the likelihood of having schizophrenia (Peralta & Cuesta 1999), and was not associated with duration of illness or its outcome (Carpenter et al 1973). Thus, first-rank symptoms seem to correlate poorly with all of the external validators of diagnostic criteria; they should perhaps be given less weight in future diagnostic criteria of schizophrenia and be considered as symptoms of psychosis rather than of schizophrenia (Peralta & Cuesta 1999).
Table 9. Comparison of diagnostic criteria for schizophrenia
|Duration||Course||Affective symptoms||Other requirements||Weight on FRS|
|DSM-IV||>6 months||Deterioration from premorbid level of functioning||Affective syndrome included if relatively brief||Substance/general medical condition exclusion||+|
|RDC||>2 weeks||-||No prominent
|ICD-10||>1 month||-||If present, must follow psychotic symptoms||Substance/general medical condition exclusion||++|
|>6 months||Chronic illness without return to premorbid level of functioning||Absence of symptoms qualifying for affective disorder||
At least 3 of 5:
(Feighner et al 1972, Spitzer et al 1978, WHO 1993, APA 1994, Hill et al 1996)
However, radical changes in diagnostic criteria always cause problems in research if results from studies using the new criteria are no longer comparable with previous findings. Because of the inconvenience relating to major changes in diagnostic criteria, the DSM-IV Work Group adopted an attitude of "progressive conservatism": changes were made only if their advantages clearly outweighed their disadvantages (Andreasen 1994). It would seem likely that this reluctance to change will continue when the DSM and ICD criteria are next updated.
Finland adopted the ICD-6 diagnostic classification for clinical use in 1954 (Lääkintöhallitus 1953). No separate criteria for schizophrenia were given in the classification. Schizophrenia was divided into seven subtypes: simple, hebephrenic, catatonic, paranoid, latent, and not otherwise specified, plus schizoaffective disorder and acute schizophrenic reaction.
The 1950s and 1960s saw a wealth of schizophrenia research in Finland. The diagnostic criteria used varied somewhat. The criteria used by Achté and Alanen were based on Langfeldt's primary symptoms of schizophrenia (Langfeldt 1969). Achté's criteria included ten malignant symptoms of schizophrenia: an alteration of character prior to the onset of illness in a previously healthy person, autism, schizophrenic disturbances in affectivity, schizophrenic association disorders, massive experiences of derealization, massive delusions of influence, massive experiences of depersonalization, specific schizophrenic hallucinations of conversation with voices or physical delusions, avolition, and catatonic stupor (Achté 1967, p. 317). A patient who clearly exhibited one or more of these symptoms was regarded as suffering from typical schizophrenia (Achté 1967, p. 317). The criteria used by Alanen et al were otherwise similar but did not include character alteration and avolition (Alanen et al 1966).
Between 1969 and 1986, the official diagnostic classification used in Finland was ICD-8 (Lääkintöhallitus 1968). The subtyping remained identical to ICD-6, and no diagnostic criteria were provided. However, the diagnostic concept of schizophrenia applied by clinicians was assessed in several studies. In a study of first-contact patients with schizophrenia or schizophreniform disorder in Helsinki in 1975, only 52% of the patients who received a DSM-III diagnosis of schizophrenia or schizophreniform disorder had received a hospital discharge diagnosis of schizophrenia or schizophreniform disorder (Kuusi 1986). In another study of all first admissions to Helsinki's two mental hospitals in 1981, 35% of the patients received a diagnosis of schizophrenia (S+) or borderline psychosis (O+) as assigned by the CATEGO computer program based on a Present State Examination-interview conducted blind to clinical diagnoses, but only 19% had received a clinical diagnosis of schizophrenia or schizophreniform disorder (Pakaslahti 1987). And in an incidence study carried out between March 1 1983 and February 29 1984 covering six health care districts in Finland, Salokangas also observed that clinicians made a DSM-III diagnosis of schizophrenia less often than an independent researcher (Salokangas 1993).Thus, the diagnostic concept of schizophrenia applied by Finnish clinicians was narrow during the 1970s and 1980s.
In 1987, the general medical diagnostic classification system in Finland was updated to ICD-9. However, the diagnostic criteria for mental disorders were adopted with slight modifications from DSM-III-R (Lääkintöhallitus 1989). In this system, the first four numbers in the diagnostic codes corresponded to the ICD-9 codes, but the fifth digit was unique to the Finnish coding system and allowed for subclassification similar to that used in DSM-III-R (Kuoppasalmi et al 1989). The diagnostic criteria for schizophrenic psychoses were identical to the DSM-III-R criteria, but unlike in DSM-III-R, schizophreniform and schizoaffective disorders were classified as schizophrenic psychoses (Kuoppasalmi et al 1989). Studies comparing research and clinical DSM-III-R diagnoses conducted in the 1990s found a continuing tendency of Finnish psychiatrists to apply a narrow definition of schizophrenia. Isohanni et al compared clinical and research diagnoses in the Northern Finland 1966 birth cohort and found 71 patients fulfilling DSM-III-R criteria for schizophrenia, whereas only 37 of them had a Finnish Hospital Discharge Register diagnosis of schizophrenia (Isohanni et al 1997). In a sample of patients from one municipality, 87% with a schizophrenia diagnosis and 18% with a schizophrenia spectrum diagnosis in the register fulfilled DSM-III-R criteria for schizophrenia (Mäkikyrö et al 1998).
Since 1996, ICD-10 diagnostic codes and criteria have been used in Finland. Thus far, the effect of this change on clinical practice has not been studied.
Schizophrenia is clinically heterogeneous. Its course and symptomatology are highly variable, which is probably one reason for the variability of results from studies on treatment, aetiology, and pathophysiology. This heterogeneity has led to a growing interest in defining specific groups of symptoms or domains of psychopathology which might be used to identify patients with a more homogenous clinical picture and, hopefully, a more homogenous aetiological background. (Rotakonda et al 1998)
The first widely used classification into symptom domains was the subdivision into positive and negative symptoms. These terms were invented by Hughlings-Jackson, who considered positive psychotic symptoms as an exaggeration of normal functioning, a release phenomenon caused by an absence of inhibitory or regulatory influences, while negative symptoms were caused by a simple loss of function. Hallucinations, delusions, disorganized speech and behaviour, and catatonic symptoms were considered as positive symptoms, while anhedonia, avolition, poverty of speech and affective blunting were classified as negative symptoms. (Andreasen 1982, Andreasen 1995)
The positive vs. negative symptom dichotomy achieved widespread use in both research and clinical work. Various rating scales for their assessment were developed (Andreasen 1982, Fenton and McGlashan 1992, Möller et al 1994). Negative symptoms were shown to be associated with poor premorbid functioning, insidious onset, intellectual impairment, and poor outcome, while the relationship between positive symptoms and outcome was less clear-cut (Crow 1985, Andreasen et al 1990, Fenton and McGlashan 1991). Negative symptoms were also associated with structural brain abnormalities and neuropsychological deficits (Andreasen et al 1990, Andreasen 1995).
Various subtypings or classifications related to positive and negative symptoms were also suggested. Andreasen and Olsen suggested a subtyping of schizophrenia into three categories - positive, negative, and mixed - based on the prominence of positive or negative symptoms, or both. They found that compared with the other two groups, patients with negative schizophrenia had significantly poorer premorbid adjustment, and poorer work and cognitive functioning. (Andreasen et al 1990, Andreasen & Olsen 1995a)
Crow suggested in 1980 that there are two syndromes in schizophrenia, each reflecting different psychopathology: Type I caused by increased number of D2 dopamine receptors, characterised by positive symptoms, good response to neuroleptics, good outcome, and absence of intellectual impairment, and Type II caused by cell loss in temporal lobe structures, characterised by negative symptoms, cerebral ventricular enlargement, poor response to neuroleptic treatment, intellectual impairment, and abnormal involuntary movements. According to Crow, these subtypes share common aetiology, but Type I reflects the neurochemical component of schizophrenia, and Type II the structural component. (Crow 1985)
Carpenter et al (1988) emphasized the distinctions between negative symptoms and disorders in relating, and between primary and secondary negative symptoms. Disorders in relating, for example social withdrawal, may be caused by loss of social drive, but also by paranoid delusions. Thus, they should not be considered as negative symptoms. Secondary negative symptoms refer to negative symptoms that are caused by drug effects, depression, or absence of social stimulation, among others. Secondary negative symptoms should be responsive to changes in the factors with which they are associated. Primary negative symptoms are less responsive to state changes and are rarely fully remitting. Carpenter et al suggested that negative symptoms should be used as a descriptive term without implications concerning cause or duration, whereas primary negative symptoms, which are present as enduring traits, should be called "deficit symptoms" . The syndrome associated with deficit symptoms was called "the deficit schizophrenia", and was associated with enduring negative symptoms, poor outcome, and a significant male excess. (Carpenter et al 1988)
The classification of symptoms as positive or negative has not always been straightforward. To solve the problem of classification, researchers applied factor-analytic techniques and consistently found that the interrelationships among the symptoms of schizophrenia are better accounted for using three dimensions: positive or psychotic, negative, and disorganized symptoms (Andreasen et al 1995a). Disorganized symptoms consist of disorganized speech, inappropriate affect, and bizarre behaviour. In a longitudinal study of the dimensions, symptoms within the three groups tended to change in unison, but the symptom groups changed independently from one another (Arndt et al 1995).
Recent studies have found that disorganized symptoms may be more familial than positive and negative symptoms: they are moderately correlated within affected sibling pairs (Cardno et al 1998, Loftus et al 1998), and are associated with an increased risk of nonaffective psychotic disorders in first-degree relatives (Cardno et al 1997, Van Os et al 1997). Negative symptoms continue to be associated with poor social outcome and poor quality of life in recent studies, while positive and disorganized symptoms do not have similar predictive value (Ho et al 1998). However, in a large follow-up study of first-episode patients with schizophrenia, only severity of positive symptoms was associated with treatment response (Robinson et al 1999), and none of the symptom dimensions was associated with relapse rate (Robinson et al 1999a).
However, the symptom dimensions of positive, negative, and disorganized symptoms are not unique to schizophrenia, being found in other psychotic disorders as well (Maziade et al 1995, Johnstone & Frith 1996, Serretti et al 1996, Rotakonda et al 1998). Moreover, associations between the symptom dimensions and clinical variables (poor premorbid functioning and negative symptoms, continuous course of illness and disorganized symptoms) have been found regardless of the diagnosis (Rotakonda et al 1998). It may be that these symptom dimensions or psychopathological domains reflect discrete pathophysiologic conditions (Rotakonda et al 1998). Consequently, it has been suggested that future aetiological research might benefit by including symptom dimensions in identifying groups to be studied (Serretti et al 1996).
There are two types of measures of occurrence: rates and proportions. A proportion is dimensionless but rate is not, because time is retained in the unit of measurement. The most common rate-type of measure of occurrence is incidence rate or incidence density. Incidence rate quantifies the number of events occurring per unit of population per unit of time, usually the number of new cases occurring in one year per 1000 or 100 000 person years. The two most commonly used proportion-type measures of occurrence are cumulative incidence and prevalence. Cumulative incidence is calculated as the number of health outcomes occurring over a time interval divided by the size of the population at risk. Cumulative incidence is a suitable measure of occurrence in cohort studies where the loss to follow-up over the course of the study is negligible. Prevalence is the proportion of a population who have a particular health condition at a point or period (one year, lifetime) in time. The prevalence of schizophrenia is determined as the total number of cases now alive, presently or previously actively psychotic, divided by the size of the population. (Zahner et al 1995, pp. 24-25, Gottesman & Shields 1982, p. 19)
A proportion-type morbidity index commonly used in population and genetic studies is lifetime morbid risk (MR) or lifetime risk. The lifetime morbid risk is the probability that a person who survives through the period of susceptibility of manifestation will develop the disorder. If n is the total number of subjects and m is the total number of affected, the raw total rate would simply be m/n, but this would underestimate the morbidity risk since some of the well subjects who have not yet lived through the period of susceptibility may still develop the disorder. To adjust for the age of the observed sample, an age-corrected denominator called Bezugsziffern (BZ) is calculated. BZ is the sum of weights reflecting each subject's length of exposure to risk up to the age of examination. If wi is the weight for the ith individual, MR is estimated by
(Faraone & Tsuang 1995, p. 115)
There is still a widely held view that the prevalence of schizophrenia is approximately 1% throughout the world (Schultz & Andreasen 1999). However, in a review of all prevalence studies conducted thus far, Torrey found a prevalence range exceeding 50-fold from the lowest (0.3 per 1000) to the highest (17 per 1000) reported (Torrey 1987). As he pointed out, all aetiological hypothesis, whether genetic, environmental or both, would predict significant differences in the prevalence of the disease; it would actually be surprising if no differences were found (Torrey 1987).
Recent studies using structured interviews and DSM-III-R criteria for schizophrenia have found prevalences that are considerably lower than the usually cited 1%. The National Comorbidity Survey, which was based on interviews of 8098 individuals representing a random sample of the United States population, found a 0.7% lifetime prevalence of all nonaffective psychotic disorders and a 0.15% lifetime prevalence of schizophrenia (Kendler et al, 1996). The lifetime prevalence of schizophrenia in the Irish Roscommon study was 0.54% in men and 0.26% in women (Kendler & Walsh 1995). In the British Hampstead Schizophrenia Survey, the point prevalence of DSM-III-R schizophrenia varied, depending on the age correction method used, between 0.3 and 0.48% (Jeffreys et al 1997).
In Finland, the lifetime prevalence of schizophrenia seems to be somewhat higher than elsewhere: 1.3% in the Mini-Finland Health Survey, which used the Present State Examination interview (Lehtinen et al 1990), and 1.2% in a register-based study (Hovatta et al 1997). In the UKKI (Uusikaupunki - Kemijärvi) study, the lifetime prevalence of all nonaffective psychotic disorders as defined by the Present State Examination was 2.7% in the population aged 30-80 years (Lehtinen et al 1990a). However, these studies were based on diagnostic criteria that are broader than the DSM-III-R criteria.
Prevalence of a disease in a population is proportional to the frequency of development of new cases only if the numbers of entries to and exits from the population are stable (Zahner et al 1995, p.26). These are dependent on birth and death rates and migration, which are rarely stable. Differences in prevalences between different countries may thus be caused by differences in migration patterns and population age structures. Therefore, incidence rates are epidemiologically more informative than prevalence (Campbell & Machin 1993, p. 117). In schizophrenia research, the use of incidence rates is preferable also because of the excess mortality among patients with schizophrenia (Brown 1997) which tends to decrease the observed prevalences.
The World Health Organization Ten Country Study has been the most systematic attempt to compare the epidemiology of schizophrenia in different countries and cultures using uniform evaluation and diagnostic criteria. The diagnostic assessment was conducted using the Present State Examination interview, and diagnoses were obtained using the CATEGO computer program. The incidence of narrowly defined schizophrenia in the ten populations aged 15-54 years varied between 0.7 and 1.4 per 10 000 person years. The differences were not statistically significant. However, the incidence of broadly defined schizophrenia varied significantly, between 1.6 and 4.2 per 10 000 person years. These findings were interpreted to suggest that the incidence of schizophrenia is similar worldwide. (Jablensky et al 1992)
Three recent studies, conducted in the Caribbean islands, applied the same methodology as the WHO Ten Country Study (Hickling et al 1995, Bhurga et al 1996, Mahy et al 1999). All found a slightly higher incidence of narrowly defined schizophrenia; 1.6 per 10 000 person years in Trinidad, 2.1 per 10 000 person years in Jamaica, and 2.8 per 10 000 person years in Barbados, while the incidence of broadly defined schizophrenia was within the limits of those observed in the WHO study (2.2, 2.4, and 3.2 per 10 000 person years, respectively) (Bhurga et al 1996, Hickling et al 1995, Mahy et al 1999). However, the incidence of schizophrenia among African-Caribbean migrants in Europe has been found to be considerably higher. In Nottingham, the incidence of ICD-10 schizophrenia was 15 per 10 000 person years among first or second generation African-Caribbean migrants when, at the same time, it was 1.7 per 10 000 person years in the rest of the host population (Harrison et al 1997). Considerably increased incidences of schizophrenia among the African-Caribbean population have also been observed in other parts of England (Castle et al 1991, Bhurga et al 1997). In The Netherlands, the risk of developing schizophrenia is approximately 4 times higher among Surinamese and Dutch Antillean immigrants than in the rest of the population (Selten et al 1997). Part of the observed increase may be caused by problems in defining the population at risk in the calculations, because not all immigrants permanently residing in a country are registered in censuses (Harrison et al 1997), and some of the hospitalized "immigrants" may actually be transient visitors (Mortensen et al 1997). Nevertheless, the observed increase is far too large to be solely explained by such confounding factors (Harrison et al 1997).
In Finland, the incidence of DSM-III schizophrenia and schizophreniform disorder among the 15-45-year-olds was 3.6 per 10 000 person years, and the incidence of ICD-8 schizophrenia among the 15-59-year-olds 2.1 per 10 000 person years in an incidence study carried out between March 1 1983 and February 29 1984 in six health care districts. Both are higher than the incidence of narrowly defined schizophrenia in the WHO study but within the range of the incidence of broadly defined schizophrenia (Salokangas 1993). In Helsinki, the incidence of DSM-III schizophrenia and schizophreniform disorder in 1975 was 1.9 per 10 000 person years (Kuusi 1986). The definition of schizophrenia in DSM-III is almost as restrictive as the narrow schizophrenia assigned by the CATEGO program, but the rates are not comparable because the age range was 15-54 years in the WHO study and 15-45 in the Finnish studies. In the UKKI (Uusikaupunki - Kemijärvi) study, the incidence of all psychotic disorders was 18 per 10 000 person years, but this includes, besides schizophrenia, all other psychotic disorders and severe personality disorders (Lehtinen et al 1996). A recent study based on the Finnish Hospital Discharge Register found that the incidence of DSM-III-R nonaffective psychotic disorders was 0.74 per 1000 person years in 1990 and 0.69 per 1000 person years in 1993 (Korkeila et al 1998).
126.96.36.199. Changes in the occurrence of schizophrenia
In the 19th century, the numbers of registered "insane" increased rapidly in England, Scotland, Ireland, France, and the United States. Numerous mental hospitals had to be built, and the numbers of first admissions rose throughout the latter part of the century and until World War I. The reasons for the phenomenon were disputed. Some thought that it was merely caused by more accurate registration, by changes in legislation that made it profitable for communities to send their mentally ill residents to mental hospitals, and by reduced mortality and increased length of stay in mental hospitals. Others insisted that despite the obvious contribution of these "nosocomial" factors, a true increase in the occurrence of insanity, particularly its more severe forms, had occurred. Edward Hare believed that it had partly been caused by a true increase in occurrence, because the rise had persisted far longer than the establishment of registration systems, it was extremely pronounced, and it had continued despite no changes in mortality in the mental hospitals. He suggested that the incidence of schizophrenia in particular had increased, because few descriptions of a disease resembling schizophrenia existed before the 19th century, and in the 18th century it was thought that young people were rarely liable to insanity. A rapid increase in the incidence of schizophrenia would also explain the rather abrupt development of interest in schizophrenia particularly during the latter part of the 19th century - although the identification of the two most important organic psychoses at that time, Korsakoff's psychosis caused by chronic alcoholism and general paresis caused by tertiary syphilis, may also have increased the interest in functional psychoses (Colp 1995). (Hare 1983, Hare 1988)
Recent research suggests that the incidence of schizophrenia may be declining. Falls in incidence (Brewin et al 1997, Balestrieri el al 1998), morbid risk (Waddington & Youssef 1994, Strömgren 1987) and first-admission rate (Munk-Jørgensen 1987, Munk-Jørgensen & Mortensen 1992, Joyce 1987, Parker et al 1985, Eagles et al 1988, Geddes et al 1993, Takei et al 1996, Der et al 1990, de Alarcon et al 1990) have been reported from Denmark (Strömgren 1987, Munk-Jørgensen 1987, Munk-Jørgensen & Mortensen 1992), New Zealand (Joyce et al 1987), Australia (Parker et al 1985), Scotland (Eagles et al 1988, Geddes et al 1993, Takei et al 1996), England (Brewin et al 1997, Der et al 1990, de Alarcon et al 1990), Italy (Balestrieri et al 1998) and Ireland (Waddington & Youssef 1994). However, the first-admission rate has not decreased in Croatia (Folnegoviæ 1990), in the Netherlands (Oldehinkel & Giel 1995) and parts of England (Harrison et al 1991, Castle et al 1991). These findings have prompted debate about whether the observed decline has been due to genuine changes in the incidence or to confounding factors such as changes in diagnostic criteria, treatment practice, or registration (Torrey 1989, Geddes et al 1993, Kendell et al 1993, Harrison & Mason 1993, Munk-Jørgensen 1995).
The reliability of studies that use register-based first-admission rates has been questioned, because the proportion of patients with schizophrenia who receive the diagnosis in their first admission compared with later admissions may change (Kendell et al 1993). This was controlled for in the study by Munk-Jørgensen and Mortensen, who found a significant decline in the incidence of schizophrenia in Denmark regardless of the definition of first admission used (Munk-Jørgensen & Mortensen 1992). However, Kendell et al found that misrecordings of readmissions as first admissions were common and accounted for a significant proportion of the observed decline in the incidence in Edinburgh (Kendell et al 1993). The proportion of patients treated exclusively as outpatients may also have changed, although Kendell et al found no significant increase in such patients (Kendell et al 1993), and studies including outpatients (Munk-Jørgensen & Mortensen 1992, Eagles et al 1988) have also detected a declining incidence.
Diagnostic criteria change. The narrowing clinical concept of schizophrenia, especially among young male patients, accounted for half of the decline in the study by Kendell et al (Kendell et al 1993). The decrease in the frequency of discharge diagnosis of schizophrenia in the United States has been explained as a result of the introduction of DSM-III (Loranger 1990, Stoll et al 1993). However, considerable variability in diagnostic practice between countries used to exist (Leff 1977). Psychiatrists in Nordic countries, for example, have traditionally applied narrow diagnostic criteria of schizophrenia in their clinical practice (Pakaslahti 1987, Isohanni et al 1997, Löffler et al 1994).
Because of the methodological shortcomings of studies (Kendell et al 1993) and -perhaps - also because of the fixed belief that the incidence of schizophrenia is constant across countries and time periods (Torrey 1989), some believe that no true change in the incidence of schizophrenia has occurred, while others are convinced that it is declining (Geddes et al 1993, Kendell et al 1993, Harrison & Mason 1993, Munk-Jørgensen 1995, Crow 1995, Crow 1995a). The decline, if genuine, suggests that the frequency or intensity of risk factors of schizophrenia in the population is decreasing - or that the frequency or intensity of protective factors is increasing.
In Finland, a decline in the incidence of schizophrenia in the southern, relatively urbanized province of Uusimaa was already observed in the 1950s (Syvänne 1952): between 1929 and 1950, the incidence decreased from 0.97 to 0.47 per 1000 person years. In Helsinki, the incidence declined from 0.85 to 0.43 per 1000 person years between 1950 and 1965 (Niskanen & Achté 1972), and in Turku from 0.49 per 1000 person years in 1949-1950 to 0.40 per 1000 person years in 1969-1970 (Salokangas 1979). A recent study based on the Finnish Hospital Discharge Register found that the first admission rate of all DSM-III-R nonaffective psychotic disorders declined from 0.74 per 1000 person years in 1990 to 0.69 per 1000 person years in 1993 (Korkeila et al 1998). However, in this study the first-ever hospitalisation for psychotic disorder was defined as having no such hospitalisations during the three years preceding the index admission (Korkeila et al 1998).
188.8.131.52. Geographical variation in the occurrence of schizophrenia
Studies indicate large differences in the prevalence of schizophrenia between different countries, and smaller but significant differences in the incidence (Torrey 1987, Torrey 1989). In addition, pockets of very high and very low prevalence have been detected (Torrey 1987). The lowest reported prevalence (0.3 per 1000, age-corrected 0.5 per 1000) has been reported among the Amish population of the United States (Torrey 1987), and the highest in a community in northern Finland (22 per 1000, age-corrected lifetime risk 3.2%) (Hovatta et al 1997). Also significant within-country variations in prevalence (Lehtinen et al 1990, Torrey & Bowler 1990, Youssef et al 1991, Hovatta et al 1997) and morbid risk (Youssef et al 1993, Hovatta et al 1997) have been observed.
The most striking differences in the occurrence of schizophrenia within countries relate to urban-rural differences. The prevalence of schizophrenia has been repeatedly observed to be higher in urban than rural areas, but previously this was assumed to be caused by social drift - patients with schizophrenia "drift" into urban areas as a consequence of their illness or its prodromal symptoms (Freeman 1994, Torrey & Bowler 1990). However, Lewis et al showed in a Swedish conscript cohort that urban upbringing, not urban residence, was associated with increased risk of developing schizophrenia in adulthood (Lewis et al 1992). The odds ratio was highest among those who had grown up in cities (Stockholm, Göteborg, Malmö) (Lewis et al 1992). Since then, several studies have found an increased risk of schizophrenia among the urban-born, particularly those born in cities (Takei et al 1995, Marcelis et al 1998, Mortensen et al 1999). A relationship between urban birth and environmental risk factors operating prenatally or early in life has been suggested (Freeman 1994, Takei et al 1995, O'Callaghan et al 1995).
Significant geographical differences in the occurrence of schizophrenia have also been observed in Finland, but here the occurrence of schizophrenia is lower in urban areas. This was already observed in the 1960s. The rates of new disability pensions granted because of schizophrenia and other psychotic disorders were highest in eastern and lowest in southwestern Finland, and within each of the studied regions the rates were higher among those living in rural areas (Suominen 1975). In a more recent study of first-contact psychiatric patients, the incidence of all psychotic disorders among the population over 15 years varied between 0.80 per 1000 in Helsinki and 1.61 in the north Karelia (Salokangas et al 1987). The prevalence of schizophrenia in the Mini Finland Health Survey varied between 0.9% in the urbanized southern and southwestern Finland and 2.1% in northern Finland (Lehtinen et al 1990), and even larger differences in prevalence were observed in a register-based study (Hovatta et al 1997). The most recent study, based on hospital treatments in 1993-1994, found that the first-admission rate of nonaffective psychotic disorders per 1000 person years varied between 0.56 in southwestern and 0.84 in eastern Finland, while the first-admission rate of affective disorders varied between 0.51 in northern and 0.84 in eastern Finland (Korkeila et al 1998). Thus, the incidence of psychotic disorders seems to have been higher in rural areas for decades, and this applies also to affective disorders, particularly in eastern Finland (Suominen 1975, Korkeila et al 1998a).
The age at onset of schizophrenia is usually defined as the age at the onset of first psychotic symptoms (interview-based studies) or at the beginning of first hospitalization for schizophrenia (register-based studies). The age at the onset of prodromal non-psychotic symptoms has also been used in some studies. Although the age at onset may vary by several years depending on the definition used (Maurer & Häfner 1995), the times of onset of behavioural change, positive symptoms, and first hospitalization are usually correlated within individuals (DeLisi 1992).
The peak age at onset of schizophrenia occurs in early adulthood (Kraepelin 1919 p. 224, Bleuler 1911 p. 341, Sham et al 1994, Castle et al 1995). Females tend to have a later age at onset than males (Castle et al 1995) and a different age at onset distribution: that among males shows a single marked peak in the early twenties, while the distribution among females is bimodal with a second peak in the 45-54-year age group (Castle et al 1995, Sham et al 1994).
The sex difference in the age at onset has not been found in all studies (Folnegoviæ et al 1990, Kendler & Walsh 1995), and this is notably the case in many Finnish studies (Kuusi 1986, Salokangas 1993, Hovatta et al 1997). Recent research suggests that the later age at onset in females may be confined to patients without a family history of schizophrenia, since no sex differences in the age at onset exist among patients with a positive family history for schizophrenia (Shimizu & Kurachi 1989, Albus et al 1994, DeLisi et al 1994, Murphy et al 1994, Albus et al 1995, Gorwood et al 1995).
The ages of onset of affected siblings are correlated. The correlation coefficient for the onset ages in pairs of affected siblings has varied between 0.24 and 0.26 (DeLisi et al 1987, Kendler et al 1987, Burke et al 1996, Cardno et al 1998). A positive family history of schizophrenia is associated with an earlier age at onset (Kendler & MacLean 1990a, Maier et al 1993, Sham et al 1994, Albus et al 1994, Alda et al 1996). Early age at onset also predicts a higher risk of rehospitalization (Eaton et al 1992), poor outcome (Loebel et al 1992), and neuroleptic resistance (Meltzer et al 1997).
A family study of patients with schizophrenia (61%), delusional disorder (31%) or schizoaffective disorder (8%) with onset after the age of 60 found no increased risk of schizophrenia in the relatives of such patients, whereas the risk of major depression was significantly higher among relatives of patients than in those of matched controls (Howard et al 1997). Because of possible aetiologic heterogeneity, the authors suggest that at least a coding for late age at onset should be included in subsequent revisions of DSM and ICD (Howard & Rabins 1997).
The question of whether schizophrenia is more common among males is controversial. Already in Kraepelin's material, males (57%) outnumbered females (43%) (Kraepelin 1919, p. 231). Some recent studies have replicated this observation (Kendler & Walsh 1995, Hovatta et al 1997), although the findings were mixed in the WHO Ten Country Study: males tended to have a higher incidence in the European centres, while elsewhere the disparity was often reversed (Jablensky et al 1992). The difference in the incidence or prevalence of schizophrenia between males and females diminishes or disappears when broader diagnostic criteria are applied and when other nonaffective psychotic disorders are included in the definition (Castle et al 1993, Goldstein 1997).
Besides a lower incidence and later age at onset, females tend to show better premorbid functioning, better social functioning, and a more benign course of illness (Salokangas 1983, Castle et al 1995, Goldstein 1997). Males have more negative symptoms and females more positive and affective symptoms (Castle et al 1994, Goldstein 1997). Males also have more structural brain abnormalities than females (Goldstein 1997).
The difference in the outcomes tends to diminish with advancing age (Goldstein 1997, Childers & Harding 1990). This, and the presence of a bimodal age-at-onset distribution among females, has been suggested to result from a protective effect of estrogen in females (Castle et al 1995, Goldstein 1997, Häfner et al 1998). In animal studies, estrogen has had effects on the dopaminergic, noradrenergic, serotonergic, and GABA (gamma-aminobutyric acid)-ergic systems (Castle et al 1995, Häfner et al 1998). However, direct evidence for this estrogen hypothesis is scarce; for example, no connection between the onset of schizophrenia and recent menopause has been observed (Castle et al 1995).
Although females seem to be somewhat less prone to schizophrenia and, when they do develop it, are more likely to have a benign course of the disorder, female sufferers with schizophrenia seem to have more risk factors for schizophrenia (Castle et al 1995). Several family studies have observed that the relatives of female patients show a higher morbid risk of schizophrenia and schizophrenia spectrum psychotic disorders than relatives of male patients (Castle et al 1995, Goldstein 1997), although others have failed to replicate this finding (Kendler & Walsh 1995). Some studies have reported that the increased risk of schizophrenia after second-trimester exposure to an influenza epidemic is confined to females (O'Callaghan et al 1991, Takei et al 1994). Castle and Murray have suggested that the reason for the sex differences in the incidence, symptoms, clinical course, and risk factors might be that there are subtypes of schizophrenia to which males and females are differently susceptible (Castle et al 1994, Castle et al 1995).
Schizophrenic patients worldwide have a 5-8% excess of births during the winter and spring months compared with the general population (Torrey et al 1997). The peak months of schizophrenic births have been between January and April in the Northern hemisphere, and between July and September in the Southern Hemisphere. However, the winter-spring excess is smaller and less consistent in the Southern Hemisphere (McGrath & Welham 1999). Within countries, the seasonal variation in some studies has been more pronounced among the urban-born than the rural-born (O'Callaghan et al 1995), while others have not detected such an association (Mortensen et al 1999). Studies of sex differences have given contradictory results, some finding more pronounced seasonality among females, others among males. Shifts in the peak of seasonal variation over time have also been observed. (Torrey et al 1997)
The cause of the seasonal variation of births in schizophrenia is unknown. A statistical artifact caused by age incidence has been suggested (Lewis 1989), and refuted (Dalén 1990, Pulver et al 1990, Torrey & Bowler 1990a, Watson 1990). It has also been suggested that parents of patients with schizophrenia have a seasonal conception pattern that is slightly different from that of the general population. This so-called procreational habits hypothesis predicts that siblings of patients should also have a winter-spring excess in their births. This has not been supported by studies conducted on the siblings of patients with schizophrenia, but the sample sizes have been relatively small. (Torrey et al 1997)
Several theories have linked seasonality of births to genetic factors, pregnancy and birth complications, nutritional deficiencies, weather effects, and to seasonal variation in light, external toxins, or hormonal levels. Studies that have investigated the association between pregnancy and birth complications and seasonal variation of births have obtained contradictory results, some finding more complications among the winter-born, others among the summer-born (Torrey et al 1997). However, sample sizes have been small. Several researchers have suggested that the winter-spring excess of births in schizophrenia may be caused by variations in maternal hormonal levels brought about by seasonal variations in light (Torrey et al 1997). The hypothesis is indirectly supported by findings of a latitude gradient in the magnitude of the seasonal variation (Torrey et al 1977). Hypotheses that link seasonal variation of births in schizophrenia to nutritional deficiencies and exposures to industrial chemicals have not been tested (Torrey et al 1997).
Several studies have investigated the association between outdoor temperature during gestation and seasonal variation of births. Asssociations between both exceptionally high and low temperatures during gestation and the magnitude of the seasonal variation have been reported, but several studies have also failed to detect any association between seasonal variation of births in schizophrenia and outdoor temperature (Torrey et al 1997). Somewhat more encouraging results have been obtained from studies searching for associations between infectious epidemics during gestation and seasonality of births in schizophrenia. However, these findings have concerned a variety of infections (Watson et al 1984, Torrey et al 1988, Takei et al 1996, Torrey et al 1997).
Classic epidemiology was interested in finding environmental risk factors for diseases, while classic genetics focused on finding genes causing or predisposing to illnesses. Genetic epidemiology is interested in both genetic and environmental causes of diseases. The basic terminology of genetic epidemiology is presented in Table 10. (Faraone & Tsuang 1995, p. 81)
Table 10. Basic terminology of genetic epidemiology
|Allele||A different form of the same gene|
|Anticipation||Exacerbation in the disease (earlier onset and/or more severe form) from parent to child|
|Association studies||Assess the association of a disease and genetic markers in unrelated patients and controls|
|Concordance||Proportion of twin pairs who are similarly affected|
|Dominant allele||An allele that is expressed if either of the pairs of a chromosome has it|
|Gene-environment interaction||Different effect of a genotype on disease risk in persons with different environmental exposures|
|Genetic heterogeneity||Different genes cause the same disorder|
|Genetic marker||A DNA sequence with a known chromosomal location|
|Haplotype||A group of closely located alleles which are inherited together as a unit|
|Heritability||Measures the degree to which genetic factors influence variability in the phenotype: if phenotypic variability (Vp) is divided into statistically independent genetic (Vg) and environmental variability (Vc), heritability (h2) can be calculated as the ratio of genetic and phenotypic variances (h2= Vg/ Vp). Specific to the population and time period studied.|
|Heterozygosity||Different alleles are present at a given locus on the pairs of a chromosome|
|Homozygosity||The same allele is present at a given locus on both pairs of a chromosome|
|Incomplete penetrance||All individuals possessing a disease gene do not manifest the disease|
|Liability||Predisposition to develop a disorder|
|Linkage||Close proximity of loci on a chromosome|
|Linkage analysis||Assesses the association of disease and a genetic marker within families|
|Locus||The site of a specific gene on a chromosome|
|Lod score||Logarithm of the odds, a statistical term that incidates whether two loci are linked. A lod score of 3 or higher is commonly accepted as showing linkage.|
|Pairwise concordance||Method of calculating concordance in which every pair of twins is counted only once|
|Penetrance||Frequency with which a particular genotype is expressed by the individuals possessing it|
|Phenocopy||Case of a particular disease caused entirely by environmental factors|
|Phenotype||The observable characteristics of an individual, determined by genetic and environmental factors|
|Proband||Name used for cases and controls in genetic studies|
|Pleiotropy||Same gene may express more than one phenotype|
|Probandwise concordance||Method of calculating concordance in which twin pairs in which both members are ascertained indepently are counted twice. Only probandwise rates can be compared directly with the general population occurrence estimates.|
|Recessive allele||An allele that is expressed only if both pairs of a chromosome have it|
|Vulnerability indicator||Any genetic, biological, psychological, or behavioural trait that may reflect liability to develop a disorder|
(Gottesman & Shields 1982, Kremen et al 1992, Kendler & Diehl 1993, Faraone & Tsuang 1995, Ottman 1996, Owen & Craddock 1996, Plomin et al 1997, Skuse 1997, Pekkarinen 1998)
Faraone and Tsuang have introduced the term "chain of genetic epidemiologic research" to describe the logical progression of questions in genetic epidemiologic research. The first question, "Is the disorder familial", is answered using a research design known as the family study method. The best designs for answering the second question, "What are the relative contributions of genes and environment", are twin and adoption studies. The answer to the third question, "What is the mode of transmission", may be found using segregation analysis. The answer to the fourth question, "Where is the gene(s) located", is, with luck, found with linkage or association studies. (Faraone & Tsuang 1995, p. 82)
Numerous family studies conducted between 1920 and 1987 have confirmed that relatives of probands with schizophrenia have an increased risk of developing schizophrenia. The risk decreases rapidly from close to more distant relatives (Table 11) (Gottesman 1994). First-degree relatives of schizophrenia probands have an approximately ten-fold risk of developing schizophrenia compared to relatives of control probands (Kendler & Diehl 1993). The relatives of probands with schizophrenia also have an increased risk of other disorders known as the schizophrenia spectrum disorders: schizotypal and paranoid personality disorder, and other nonaffective psychotic disorders (Kendler & Diehl 1993).
The results of the most recent epidemiologic family study, the Irish Roscommon Family Study, are of special interest because of the use of the most sophisticated methodology and systematic case ascertainment of all the family studies conducted thus far. The study included three proband groups: schizophrenic, affective, and control. Probands and all available first-degree relatives were interviewed and rediagnosed according to DSM-III-R diagnostic criteria. For the deceased and those who could not be traced or refused to be interviewed, the diagnosis was based on case note information and family history interview. After diagnostic evaluation, probands were classified into 7 groups: schizophrenia, schizoaffective disorder, schizotypal personality disorder, other nonaffective psychosis, psychotic affective illness, nonpsychotic affective illness, and controls. (Kendler et al 1993a)
The morbid risks of schizophrenia and schizophrenia spectrum disorders and affective illnesses are presented in Table 12. The numbers are based on morbid risks among relatives who were personally interviewed. The study confirmed the higher risk of schizophrenia among relatives of probands with schizophrenia, schizoaffective disorder, schizotypal personality disorder and other nonaffective psychosis, compared with relatives of controls. The risk of schizophrenia was also higher among relatives of probands with psychotic affective illness. Among relatives, the risk of schizophrenia was significantly higher in siblings than in parents. (Kendler et al 1993a)
The morbid risk of schizoaffective disorder was, compared with relatives of controls, significantly higher only among relatives of probands with psychotic affective illness. When schizoaffective disorder and other nonaffective psychosis were merged into a single diagnostic group, the relatives of probands from all groups except nonpsychotic affective illness had a significantly higher risk of these combined nonaffective psychotic disorders than relatives of controls. (Kendler et al 1993b)
The morbid risk of schizotypal or paranoid personality disorder was significantly higher among relatives of probands with schizophrenia and schizoaffective disorder, and almost significantly higher among relatives of probands with schizotypal personality disorder, other nonaffective psychotic disorder, and nonpsychotic affective disorder than among relatives of controls. In the relatives of schizophrenic, schizoaffective, and schizotypal probands, the prevalence of schizotypal or paranoid personality disorder was more than twice as large in parents as in siblings. (Kendler et al 1993c)
The morbid risk of all affective illnesses was significantly higher only among relatives of probands with schizoaffective illness compared with relatives of controls. The risk of bipolar affective illness was significantly higher among relatives of probands with psychotic affective illness and almost significantly higher among relatives of probands with schizoaffective illness than among relatives of controls. However, a substantially higher proportion of affectively ill relatives of schizophrenic vs. control probands had psychotic, especially mood-incongruent psychotic, symptoms. (Kendler et al 1993d)
The findings from another large family study using modern diagnostic criteria are mainly consistent with the Roscommon findings, but some differences emerged. The Iowa Study was a follow-up and family study of 510 consecutive cases with a discharge diagnosis of schizophrenia admitted to the Iowa Psychopathic Hospitals from 1934 to 1944, which used structured interviews and DSM-III diagnostic criteria (Kendler et al 1985). As with the Roscommon Study findings, the risk of schizophrenia was increased not only among relatives of probands with schizophrenia or a schizophrenic spectrum disorder but also among those of probands with psychotic affective illness (Kendler et al 1985, Kendler et al 1986). Another family study also found an increased morbid risk of schizophrenia in the relatives of probands with major depressive disorder with mood-incongruent psychotic features, although this was not statistically significant due to the small sample size (Maj et al 1991). The relatives of probands with schizoaffective disorder had as a high risk of schizophrenia as relatives of probands with schizophrenia, but only the risk of bipolar affective illness was higher among relatives of probands with schizoaffective disorder than among relatives of controls, while the risk of unipolar affective disorder was similar to that in the relatives of controls in the Iowa Study (Kendler et al 1986). In the smaller family study, the risk for major affective disorders was not increased in the relatives of probands with DSM-III-R schizoaffective disorder, depressive type (Maj et al 1991).
Family studies have thus consistently shown that schizophrenia is familial, a predisposition that is not limited to schizophrenia, but to a spectrum of related disorders. This so-called schizophrenia spectrum includes schizoaffective disorder, schizophreniform disorder, schizotypal personality disorder, paranoid personality disorder, and delusional disorder. The findings of increased risk of schizophrenia among relatives of probands with psychotic affective illness and the frequent occurrence of psychotic symptoms among affectively ill relatives of schizophrenic probands certainly present a challenge to the decision about which disorders to include in the schizophrenia spectrum, and also to the delineation of the diagnostic boundaries of schizophrenia, schizoaffective disorder, and psychotic affective illness.
184.108.40.206. Twin studies
Twin studies offer a powerful method of disentangling the effects of genetic and environmental factors. Monozygotic twins have almost identical genomes, while dizygotic twins share only approximately half of their genes. Both usually share the same rearing environment. Thus, if environmental factors entirely explain the familial clustering, there should be no differences in the concordances between monozygotic and dizygotic twins. Conversely, if genetic factors are important, the concordance should be considerably higher among monozygotic than dizygotic twins. If genetic factors alone were sufficient determinants, there should be a 100% concordance among monozygotic twins. The comparison of discordant monozygotic twins helps to identify environmental factors predisposing to or protecting from schizophrenia. Also, the variability of abnormality in monozygotic twins helps to identify less severe variants of the same underlying vulnerability. (Gottesman & Shields, pp. 72-73)
Twin studies have shown that the heritability of schizophrenia in different populations is high (Kendler & Diehl 1993, Cannon et al 1998, Cardno et al 1999). In a Finnish national twin cohort, the heritability of schizophrenia was 83%; the remaining 17% of the variance in liability was due to unique environmental factors, while common environmental factors seemed to have no influence on the liability (Cannon et al 1998). The probandwise concordance was 46% among monozygotic twins, and 9% among dizygotic twins (Cannon et al 1998). The results from a British study were almost identical: the heritability was 83%, the rest of the liability being best explained by unique environmental factors (Cardno et al 1999). The concordance was 41% among monozygotic and 5% among dizygotic twins (Cardno et al 1999).
The importance of genetic factors also emerged in two studies that investigated the risk of schizophrenia and schizophrenia spectrum disorders among offspring of identical twins discordant for schizophrenia (Gottesman & Bertelsen 1989, Kringlen & Cramer 1989). In the Danish twin study, there was no significant difference in the morbid risk of schizophrenia between offspring of affected twins (10%) and unaffected co-twins (17%) (Gottesman & Bertelsen 1989). However, sample sizes were quite small: three schizophrenic probands had a total of 14 offspring, 1 of whom was affected, while 6 unaffected cotwins had 24 offspring, 4 of whom were affected (Gottesman & Bertelsen 1989). The sample size in the Norwegian twin study was larger (Kringlen & Cramer 1989). Of the 28 offspring of schizophrenic twins, five (18%) had a schizophrenia spectrum disorder, whereas 2 of the 45 offspring of unaffected co-twins had a schizophrenia spectrum disorder (4%) (Kringlen & Cramer 1989). These differences were not statistically significant (Kringlen & Cramer 1989). Although both of these studies lacked statistical power, they suggest that unaffected monozygotic cotwins tend to carry the genotype predisposing to schizophrenia, but that it remains unexpressed in them - for example, because they have not been exposed to environmental risk factors (Gottesman & Bertelsen 1989).
The studies of discordant monozygotic twins have also given clues about environmental risk factors. The findings of higher concordance rates among monochorionic (twins sharing the same placenta and chorion) than dichorionic monozygotic twins (Davis & Phelps 1995), greater intrapair differences in finger ridge count among monozygotic twins discordant for schizophrenia than among normal monozygotic twins (Bracha et al 1992), and higher frequency of serious perinatal complications in the affected co-twin (Torrey et al 1994) suggest the involvement of prenatal environmental factors.
Twin studies, in summary, suggest that genetic factors are the most important risk factors for schizophrenia. However, environmental factors are also important: less than half of individuals with an identical genome - identical twins - are concordant for schizophrenia.
220.127.116.11. Adoption studies
Adoption studies compare the effects of different rearing environments among groups that are assumed to be similar in their genetic predisposition, and the effects of different genetic predisposition among groups that are assumed to have similar rearing environments.
In the adoptees' families design, the probands are adoptees who have developed schizophrenia in adulthood and unaffected control adoptees. The psychiatric status of the biological and adoptive relatives is investigated. If genetic factors are important, the rate of schizophrenia should be higher among the biological than adoptive relatives of an affected adoptee. If the rearing environment is important, more abnormalities should be observed among the adoptive families of affected than unaffected adoptees. (Gottesman & Shields 1982, pp. 76-77)
The largest study to use the adoptees' families design was the Danish Adoption Study of Schizophrenia (Kety et al 1994). This found significantly increased risks of DSM-III schizophrenia, schizoaffective disorder, and schizotypal personality disorder among biological relatives of probands with the same disorders than among relatives of control probands, but no increased risk among adoptive relatives of affected vs. control probands (Kety et al 1994, Kendler et al 1994).
In the adoptees method, the parent with schizophrenia is the proband. The identification of probands can follow two paths. One starts with patients with schizophrenia who have children, and locates those children who have been adopted. The alternative path identifies all adoptees and selects those whose biological parent or parents have schizophrenia. After the probands have been identified, the rate of occurrence of schizophrenia among their adopted children is compared with the rate among adoptees with unaffected biological parents. If genetic factors are important in the aetiology of schizophrenia, the rate of schizophrenia should be higher among those with an affected biological parent. (Gottesman & Shields, pp. 75-76)
The largest and most recent study to use the adoptees method was the Finnish Adoptive Study of Schizophrenia (Tienari et al 1994, Wahlberg et al 1997). The findings confirm the genetic contribution in schizophrenia: 8.4% of the adopted offspring of probands with schizophrenia developed a non-affective psychotic disorder compared with only 0.5% of the the adopted offspring of control probands (Tienari et al 1994). However, a gene-environment interaction also emerged in the study (Wahlberg et al 1997). When the adoptees were tested for schizophrenic thought disorder at the mean age of 21, only those adoptees whose biological mother had had schizophrenia and whose adoptive parents showed a high level of communication deviance displayed schizophrenic thought disorder (Wahlberg et al 1997). This was not observed among adoptees who only had a biological mother with schizophrenia or adoptive parents with a high level of communication deviance (Wahlberg et al 1997).
Adoption studies confirm the importance of genetic factors in the aetiology of schizophrenia. The Finnish Adoptive Study has provided evidence for gene-environment interaction in the development of schizophrenia.
18.104.22.168. High-risk studies
The third method used to separate the contribution of genetic and environmental factors in the aetiology of schizophrenia is the high-risk method, which is also feasible for identifying early indicators of an emerging schizophrenia (Cornblatt & Obuchowski 1997). In high-risk studies, individuals who have a higher risk of developing schizophrenia than those in the general population are identified in childhood and followed up through the risk period for developing schizophrenia. Typically, high-risk samples consist of offspring of schizophrenic parents. The best-known high-risk studies of schizophrenia are the Copenhagen High Risk Project (Cannon & Mednick 1993), the New York High-Risk Project (Erlenmeyer-Kimling et al 1997), and the Israeli High-Risk Study (Ingraham et al 1995).
The largest of the high-risk studies is the Copenhagen High Risk Project, which has followed up 207 children born to mothers with chronic schizophrenia and 104 controls with healthy parents for more than 30 years (Cannon & Mednick 1993). Their findings again support the strong effect of genetic factors in the development of schizophrenia: the prevalences among offspring of schizophrenic mothers vs. controls were 16.2% vs. 1.9% for DSM-III-R schizophrenia, 4.6% vs. 0.9% for DSM-III-R other nonaffective psychotic disorders, and 21.3% vs. 5% for schizotypal, schizoid, and paranoid personality disorders (Parnas et al 1993). However, they also found that offspring of schizophrenic mothers who later developed schizophrenia had had significantly more birth complications than high-risk subjects who remained unaffected (Parnas et al 1982). Offspring of schizophrenic mothers who had a schizophrenia spectrum personality disorder had had less birth complications than those who had developed schizophrenia and those who remained unaffected (Parnas et al 1982). Birth complications interacted with genetic risk in determining cerebral ventricular enlargement in high-risk subjects (Cannon et al 1993a). Severe instability in the early rearing environment was another risk factor for schizophrenia among the high-risk subjects (Cannon & Mednick 1993).
The New York High Risk Study includes, besides offspring of schizophrenic parents and controls, a third group consisting of offspring of parents with a severe affective disorder. The findings are of interest in relation to the diagnostic boundaries of the schizophrenia spectrum. While schizophrenia and other nonaffective psychotic disorders except schizoaffective disorder occurred only among offspring of schizophrenic parents, RDC schizoaffective disorder, mainly schizophrenic type, was more common and RDC schizoaffective disorder, mainly affective type, less common among the offspring of parents with affective disorder than among those of schizophrenic parents. Affective psychoses were equally common among both high-risk groups. Otherwise, the New York High Risk Project has focused more on detecting early biological and behavioural markers of schizophrenia than on identifying environmental risk factors for schizophrenia. (Rosenberg et al 1997, Erlenmeyer-Kimling et al 1997, Freedman et al 1998)
The Israeli High-Risk Study consists of 50 offspring of schizophrenic parents, half of whom were raised in a kibbutz, the other half by their biological parents, and 50 control offspring of healthy parents similarly raised either in a kibbutz or by their biological parents. Schizophrenia occurred only among high-risk subjects and equally among those reared in a kibbutz or by their biological parents. (Ingraham et al 1995)
In Finland, Gunnel Wrede began a high-risk study of schizophrenia in the 1970s. Cases had been born in Helsinki between 1960 and 1964 to schizophrenic mothers. The mothers had been born between 1916 and 1948 and treated in Hesperia hospital for a psychotic disorder. The children have not yet been followed up in adulthood, but they did experience more pre- and perinatal complications than controls born in the same hospitals (Wrede et al 1980). In adolescence, the children born to mothers with paranoid schizophrenia were significantly better functioning socially than their peers from the same class, while the social functioning of other high-risk subjects was slightly worse than their peers. (Wrede 1984)
Results from high-risk studies provide strong support for the importance of genetic factors in the development of schizophrenia, but they also emphasise the existence of environmental risk factors and gene-environment interactions.
The three simple Mendelian modes of inheritance are autosomal recessive, autosomal dominant, and X-linked. In autosomal recessive inheritance, only probands who are homozygotic for the disease allele are affected. Both parents of the affected probands are usually unaffected but 25% of their siblings are affected. The proband's children and more distant relatives are rarely affected. In autosomal dominant inheritance, probands who are heterozygotic for the disease allele are also affected. One of the proband's parents is always affected, as well as 50% of siblings and children, and there is usually a long family history of the disorder. The third mode is X-chromosome linked inheritance, which is usually recessive; the X-linked dominant mode of inheritance is extremely rare. A female with one X-linked recessive allele will not show the disease, but half of her sons will be affected, while half of her daughters will be unaffected carriers. A male with an X-linked recessive allele can only have received the allele from his mother. He cannot transmit the disease to his sons, but half of his daughters will be unaffected carriers. (Gottesman & Shields 1982, pp. 60-62)
A new mutation class - the so-called dynamic mutations caused by unstable DNA - identified in the beginning of the 1990s may obscure the otherwise Mendelian pattern of inheritance. Unstable DNA consists of pathologically expanding DNA nucleotide triplets. These DNA sequences display a marked tendency to amplify when transmitted from parent to child. The person will remain asymptomatic until a certain number of triplet repeats, after which symptoms start to emerge with increasing severity depending on the number of repeats. Huntington's disease and Fragile X syndrome are examples of triplet repeat diseases. Typical of these diseases is a phenomenon called anticipation, a tendency of symptoms to get worse and age at onset to become earlier from one generation to the next. (Petronis & Kennedy 1995, O'Donovan & Owen 1996)
Besides single gene mendelian transmission, there are three other types of transmission models: single major gene, oligogenic, and multifactorial polygenic. Single major gene models suggest that there is one major gene which accounts for most of the genetic transmission of a disorder, but other genes and environmental conditions may also have some minor effect. Oligogenic models assume that there are several genes whose combined action causes the illness. The action of the genes may be additive or interactive (epistatic, meaning that the combined effect of the genes is more or less than the sum of their separate effects). (Faraone & Tsuang 1995, p. 95)
Multifactorial polygenic inheritance means that a large number of genes of small effect occur simultaneously and combine with environmental effects to determine the outcome. The difference between oligogenic and multifactorial polygenic models is one of degree: there are several, but perhaps less than ten, genes in the oligogenic model, while there may be even hundreds of genes in the multifactorial polygenic model. Polygenic inheritance is characterized by a clinical range of outcomes from borderline to severely affected, by severely ill probands having more affected relatives than mildly ill probands, by the increasing risk to relatives with greater numbers of affected family members, by a sharply decreasing risk from close to more distant relatives, and by a distribution of cases on both maternal and paternal sides of a family. Multifactorial polygenic models assume that the liability to develop a disorder is normally distributed, and that individuals above a certain threshold manifest the disorder. There may be different thresholds for mild and more severe forms of the disorder. (Gottesman & Shields 1982 p. 63, Faraone & Tsuang 1995 pp. 95-96)
Analyses that assess the mode of transmission are called segregation analyses. Unfortunately, they have not been successful in identifying the mode of transmission of schizophrenia, and almost all modes of transmission have their supporters (Crow 1995, Crow 1995a, Tsuang & Faraone 1995, Owen & Craddock 1996).
The search for genes conferring vulnerability to schizophrenia started in the 1980s with linkage analysis studies of large, densely affected families (Kendler & Diehl 1993). Initially, there were some promising findings in individual studies, but replication studies failed to support the observed linkages (Kendler & Diehl 1993).
Developing methodology in the 1990s has made genomewide scans feasible, and a number of genomewide scans have been conducted in recent years. The results, summarized in Table 13, have been somewhat disappointing. Findings suggesting linkage have been made in nearly all human chromosomes, but replications have been rare. The most promising areas remain more or less a matter of opinion. Worldwide, they might be located on the short arms of chromosomes 2, 6, 8, and 10. (Crow & DeLisi 1998, DeLisi 1999, DeLisi & Crow 1999a)
As a part of The Genetic Epidemiology and Molecular Genetics of Schizophrenia in Finland project, one genome scan and one study focusing on previously identified linkages have recently been completed.
In the genome scan conducted in pedigrees originating from a genetically isolated community in Finland, the strongest evidence for linkage was obtained from chromosome 1q (Hovatta et al 1999). Although none of the previous genomewide scans have found evidence for linkage in this area, a balanced translocation strongly associated with schizophrenia and other psychotic disorders has been found close to this area in a Scottish pedigree (Devon et al 1998). The next promising area was on chromosome 4q, where some evidence of linkage has been observed in previous genomewide scans, although in an area somewhat proximal to this finding (DeLisi 1999). The third region with a lod score over two was located on Xp, where previously weak evidence for linkage has again been observed (Hovatta et al 1999). In a study that investigated candidate regions on chromosomes 3p, 5q, 6p, 20p, and 22q on an independent sample of large Finnish pedigrees, some evidence for linkage was found on chromosomes 5p, 6p, 8p, and 20p, although the maximum lod score did not exceed 2 in any of the regions (Hovatta et al 1998).
Genomewide scans are one strategy for identifying genes predisposing to schizophrenia. Another widely used strategy is to study candidate genes. The problem with such studies is that because the pathogenetic mechanism of schizophrenia is obscure, the possibly defective biochemical pathways are not known. (DeLisi 1999)
Dopamine receptor genes have been widely studied. Except for increased homozygosity of the D3 receptor among patients with schizophrenia, the findings have been negative. Findings concerning N-methyl-D-aspartate receptors, catechol-O-methyltransferase and apolipoprotein E4 have equally been negative. Controversial, weak positive findings exist on the serotonin 2A receptor, á-7 nicotinic acetylcholine receptor, some HLA-alleles, and a gene coding for an aspect of the potassium channel. Overall, candidate gene studies conducted thus far have failed to identify any genes related to schizophrenia. (DeLisi 1999)
Some rare chromosomal translocations and other chromosomal aberrations have been linked with schizophrenia. A microdeletion on chromosome 22q11 causing the velo-cardio-facial syndrome has repeatedly been associated with schizophrenia (Murphy & Owen 1996, DeLisi 1999). Patients with the velo-cardio-facial syndrome or CATCH-22 have a 10-30% risk of developing nonaffective psychotic disorder (Murphy & Owen 1996). A few studies have detected balanced translocations or other chromosomal aberrations in single pedigrees (Tsuang & Faraone 1995, DeLisi 1999). Some evidence of the involvement of dynamic mutations in schizophrenia has also been obtained (DeLisi 1999).
Overall, the findings from genetic studies are modest compared with the efforts invested. There are, however, several reasons why this should be so. The uncertainty of the correct phenotypic definition of schizophrenia or schizophrenia spectrum disorders, incomplete penetrance, and genetic heterogeneity make schizophrenia even more complex than most other complex disorders (Kendler & Diehl 1993). It may be that there are no genes of major effect involved in the aetiology of schizophrenia (Owen & Craddock 1996), and large family studies may not be the correct method to search for genes of minor effect. Besides, densely affected pedigrees may actually be more likely to have multiple disease genes segregating than smaller ones (Owen & Craddock 1996). Association studies and those focusing on genetic isolates have been offered as one solution (Owen & Craddock 1996). It has also been suggested that hypothesis-driven research should be emphasised more than the current approach of trying first to find the gene and only after that the cause (DeLisi 1999).
There was already speculation about infections being involved in the aetiology of schizophrenia back in Kraepelin's and Bleuler's times (Kraepelin 1919 pp. 240-241, Bleuler 1911 pp. 343-344): the spirochete causing neurosyphilis had been identified, and it seemed that the involvement of infections in the aetiology of schizophrenia at least could not be ruled out. Psychotic symptoms associated with influenza infections during the pandemic of 1918-1919 fuelled these speculations. The infectious aetiology theory was then forgotten until findings of abnormalities in the immune system among patients with schizophrenia, and observations that viruses were capable of causing new symptoms decades after the primary infection, revived interest in the early 1970s. (Yolken & Torrey 1995)
There are several hypotheses on how an infection could cause schizophrenia. It could be a direct result of an active infection which disrupts cellular and molecular functioning. Or a viral infection might act in a more subtle way, for example by mimicking CNS transmitters or receptors. Schizophrenia could also be caused by a latent virus that is periodically reactivated, or by retroviral genomic material integrated into host-cell DNA. Finally, it has been suggested that it is the immune response, rather than an initial infection, that is responsible for the development of schizophrenia. The suggested timing of the infection varies from the prenatal period to the onset of schizophrenia. (Kirch 1993)
Indirect evidence for an involvement of infections comes from findings suggesting a dysfunction of the immune system and from ecological studies. Abnormalities in the immune system reported in patients with schizophrenia include alterations in peripheral lymphocyte populations (Nikkilä et al 1995), an increased number of atypical peripheral lymphocytes (Yolken & Torrey 1995), protein and immunoglobulin abnormalities in the cerebrospinal fluid (CSF) (Ahokas et al 1985, Yolken & Torrey 1995), increased frequency of antinuclear and other autoantibodies (Yolken & Torrey 1995, Spivak et al 1995), and various abnormalities in cytokine concentrations (Yolken & Torrey 1995, Naudin et al 1997, Rothermundt et al 1998).
Ecological or population correlation studies compare cross-sectional population data for both exposure and disease occurrence. In schizophrenia epidemiology, ecological studies have been used to investigate whether infectious epidemics or other insults during the prenatal development are associated with an increased risk of the later development of schizophrenia. Ecological studies cannot prove a causal relationship but they are particularly useful for hypothesis generation. (Breslow & Day 1987, p.4)
Several ecological studies have investigated the association between prenatal exposure to influenza epidemics and later development of schizophrenia. Most (Mednick et al 1988, Barr et al 1990, Takei et al 1996a, O'Callaghan et al 1991, Kunungi et al 1995, McGrath et al 1994, Takei et al 1995a), but not all (Torrey 1988, Susser et al 1992, Erlenmeyer-Kimling et al 1994) have found an association between second-trimester exposure to an influenza epidemic, especially the worldwide 1957 epidemic, and later development of schizophrenia. The original finding was reported from Helsinki (Mednick et al 1988), and the authors were able to locate prenatal clinic records from a sample of mothers of patients who later developed schizophrenia. The mothers who had been exposed to the influenza epidemic during the second trimester had reported influenza-like infection significantly more often (87%, 13/15) than mothers who had been exposed during the first or third trimester (20%, 2/10) (Mednick et al 1994). Others have also observed that mothers of patients with schizophrenia who had had influenza during gestation had had it significantly more often in the second than in the first or third trimester (Wright et al 1995). It has been suggested that a proportion of the genetic predisposition for schizophrenia might be mediated by genes controlling the maternal immune response to gestational influenza (Wright et al 1995). However, the findings concerning the association between prenatal influenza and schizophrenia have not been consistent; notably, the findings from the two cohort studies were negative (Crow & Done 1992, Cannon et al 1996). Other infections have been investigated less frequently, and replicated associations have generally not been found (Watson et al 1984, Torrey et al 1988, O'Callaghan et al 1994).
Direct evidence of an infection has been sought by studies on antibodies, antigens, and the viral genomes. Studies on peripheral and CSF viral antibodies have sometimes reported elevated concentrations of various antibodies, but consistent elevations against a specific causal agent have not been detected (Ahokas et al 1987, Yolken & Torrey 1995). Findings concerning viral antigens and the viral genome have also usually been negative (Yolken & Torrey 1995), recent results on Borna disease virus being an exception.
Borna disease virus infects a broad range of warmblooded animals (Lipkin et al 1997). It has a predilection for neurons of the limbic system, and it causes a variety of neurological symptoms in affected animals but may also run a life-long latent course (Bode et al 1988, Lipkin et al 1997). Increased prevalences of Borna disease-specific antibodies have been found in psychiatric patients, both among those with affective disorders (Bode et al 1988) and those with schizophrenia (Waltrip et al 1995, Iwahashi et al 1997). Borna disease virus proteins have been detected in the CSF of patients with major depression (Deuschle et al 1998), and Borna disease virus genome transcripts from the postmortem brain samples of patients with schizophrenia and bipolar disorder (Salvatore et al 1997). Although positive findings are limited to a small minority of patients (2-10%), they are intriguing and certainly encourage study of the role of Borna disease virus in the aetiology of schizophrenia and other mental disorders.
Enteroviruses belong to the picornaviruses, small RNA-viruses, and consist of polio viruses, coxsackie viruses, echo viruses, and other enteroviruses (Hovi 1998). Enteroviruses are good candidate agents for involvement in the aetiology of schizophrenia, because 1) they cause CNS infections: they are the most common cause of viral aseptic meningitis and also cause encephalitis (Muir & van Loon 1997), 2) acute infections may be accompanied by psychotic symptoms (Wang et al 1996), 3) they may cause fetal infections leading to cerebral ventriculomegaly (Dommergues et al 1994), 4) they may persist in the body for years (Hovi 1998), and 5) they may cause new symptoms decades after the primary infection (Bruno et al 1994).
A contribution of a prenatal polio virus infection to the development of schizophrenia has been suggested, because a decline in the incidence of schizophrenia occured in many countries after the introduction of polio vaccination (Eagles 1992, Squires 1997). It has been suggested that the winter-early spring excess of schizophrenic births is caused by an infection during the second trimester of fetal development (Huttunen et al 1994). If so, polio virus epidemics, which peak in late summer and early autumn (Nathanson & Martin 1979), are a better candidate to explain the seasonality than the winter and spring infections usually suggested (Eagles 1992). There is also a similar geographical variation in the seasonality of poliomyelitis epidemics (Nathanson & Martin 1979) and schizophrenic births (Torrey et al 1977). Environmental survival of polio viruses is very sensitive to both humidity and temperature (Nathanson & Martin 1979). In areas with high relative humidity and low variation in temperature, the annual variation in the incidence of poliomyelitis was low, while it was very high in areas with large temperature and humidity variations. In the United States, the seasonal variation in the incidence of poliomyelitis was highest in the New England states and lowest in the West South Central states (Texas, Louisiana, Arkansas, Oklahoma). Similarly, the seasonal variation of births in schizophrenia was most pronounced in New England and least pronounced in the southern United States (Torrey et al 1977). Further support for the hypothesis comes from the latency of the effect of poliovirus. Decades after the primary infection, new symptoms - the so-called post-polio syndrome - can emerge (Bruno et al 1994, Dalakas 1995). Acute polio infection of the central nervous system affects, besides motor neurons and motor cortex, the hypothalamus, thalamus, cerebellum, and reticular formation in the brain stem, areas that partially correlate with those in which brain lesions have been observed in schizophrenia (Bruno et al 1994, Dalakas 1995a, Heckers 1997).
Thus far, few studies have investigated the possible role of enteroviruses in the aetiology of schizophrenia. Two previous studies have compared the incidence of paralytic poliomyelitis and the number of schizophrenic births (Watson et al 1984, Torrey et al 1988). The first detected no association (Watson et al 1984), while the second found a significant coherence between schizophrenic births and poliomyelitis - a finding difficult to explain because poliomyelitis preceded the schizophrenic births by 18 months (Torrey et al 1988). In neither of these studies was the place of birth of the patients known. A third study found no relationship between the number of deaths caused by poliomyelitis and schizophrenic births (O'Callaghan et al 1994) - however, death is a rare outcome of polio virus infection. Rantakallio et al found that neonatal meningitis caused by Coxsackie B5, another enterovirus, was associated with an increased risk of adult schizophrenia (Rantakallio et al 1997).
The association between pre- and perinatal complications and later development of schizophrenia has been convincingly demonstrated. Birth cohort studies, in which a general population birth cohort born in a certain area in a limited time period has been followed up from prenatal period until adulthood, have consistently found an association between pre- and perinatal complications and later development of schizophrenia (Sacker et al 1995, Hollister et al 1996, Jones et al 1998), although only on a trend level in the American study (Buka et al 1993). In the Northern Finland 1966 Birth Cohort Study, low birth weight (<2500g), short gestation and low Apgar scores after birth were associated with an increased risk of later development of schizophrenia. Low birth weight was also found to be a risk factor in the British Perinatal Mortality Survey (Sacker et al 1995). In the Danish Perinatal Cohort, Rhesus incompatibility (mother Rhesus D-negative, child Rhesus D-positive) was a risk factor for schizophrenia (Hollister et al 1996). The British Perinatal Mortality Survey also observed that mothers of children who developed schizophrenia were more often Rhesus negative than the mothers of other members of the cohort (Sacker et al 1995). In a meta-analysis of all case-control studies conducted thus far, the pooled odds ratio for exposure to obstetric complications and subsequent development of schizophrenia was 2.0 (Geddes & Lawrie 1995).
Prenatal insult is also suggested by the excess of minor physical anomalies observed among patients with schizophrenia, although these are at least partially determined by genetic factors (O'Callaghan et al 1991a, Murphy & Owen 1996a, Ismail et al 1998). A study of monozygotic twins discordant for schizophrenia found that they had greater intrapair differences in finger ridges than normal control twins (Bracha et al 1992). This is consistent with a second trimester insult affecting the two twins differently, because differences in finger ridges mainly reflect differences in fetal size during the second trimester (Bracha et al 1992). Extreme maternal stress (caused by loss of a spouse or sudden outbreak of a war) during the second trimester of pregnancy has also been associated with an increased risk of later development of schizophrenia (Huttunen & Niskanen 1978, Van Os & Selten 1998).
The British Perinatal Mortality Survey also observed that the physique, mental health and lifestyle of the mothers of children who later developed schizophrenia was significantly different from that of other mothers (Sacker et al 1995). They were more likely to have low weight before pregnancy, more often suffered from mental health problems, more often smoked during pregnancy, made fewer visits to antenatal clinics, and their average parity was greater (Sacker et al 1995). Mothers who have schizophrenia have more pregnancy and birth complications than control mothers, and the children of schizophrenic mothers more often have low birthweight and poor neonatal condition (Wrede et al 1980, Sacker et al 1996). Therefore, the association between obstetric complications and later development of schizophrenia might also partially reflect characteristics of the mother instead of being a true risk factor for schizophrenia (Sacker et al 1995).
The effect of prenatal nutrition on the risk of later developing schizophrenia has been investigated in the Dutch Famine Study (Susser et al 1998). This study has investigated the occurrence of various neurodevelopmental disorders among a cohort of children who were exposed to severe famine while in utero during the winter of 1944-1945. The German blockade in The Netherlands caused a severe famine that lasted from October 1944 to May 1945. Individuals who had been conceived during the height of the famine between February and April 1945 and had thus been exposed to famine during the first trimester showed a twofold increase in the risk of schizophrenia (Susser et al 1996) and also an increased risk of schizoid personality disorder (Hoek et al 1996). Individuals exposed to the famine during the second trimester of fetal development had an increased risk of later developing affective psychosis, which was statistically significant in males but not in females (Brown et al 1995).
Psychodynamic theories have considered disturbed early interaction between parents and child to be an important factor in the development of schizophrenia (Alanen et al 1966, Alanen 1990). However, as a result of vast biological research the family environment has been seen as less and less important; Weinberger stated in his 1995 Lancet review of the aetiology and pathophysiology of schizophrenia that "decades of scientifically unfounded psychological and social theories that blamed families and society have given way to increasingly compelling scientific evidence that schizophrenia is a brain disorder" (Weinberger 1995). Does the childhood rearing environment, then, have any effect on the risk of developing schizophrenia? Several recent studies suggest that the early rearing environment might indeed have such an impact. In the 1946 British Birth Cohort Study, mothers of children who later developed schizophrenia had worse than average general understanding and management of their children, although none of them was known to be mentally ill (Jones et al 1994). In the Northern Finland 1966 Birth Cohort, being a child from an unwanted pregnancy was significantly associated with the later development of schizophrenia (Myhrman et al 1996). However, being from a single-parent family was not associated with the risk of developing schizophrenia or other psychotic disorders (Mäkikyrö et al 1998a), neither was maternal depression during pregnancy (Veijola et al 1998). In the Finnish Adoption Study, schizophrenic thought disorder was observed only among those children whose biological mother had schizophrenia and whose adoptive parents showed high communication deviance (Wahlberg et al 1997), a finding suggested in a previous high-risk study (Miklowitz 1994). In the Copenhagen High-Risk Study, severe instability in the early rearing environment was associated with an increased risk of adult schizophrenia (Cannon & Mednick 1993). Thus, the possibility that the childhood rearing environment might be a risk factor for - or a protective factor against - the later development of schizophrenia should not be discarded.
It has been convincingly demonstrated that both genetic and environmental factors are important in the aetiology of schizophrenia, but how do their effects combine to produce the disorder? This problem of mechanism of action and interactions of genetic and environmental risk factors is common to all aetiologic research on complex diseases (Ottman 1996).
Kremen et al (1992) and Tsuang et al (1990) have presented alternative aetiological models of schizophrenia and research strategies with which to test them. The strategies to study vulnerability indicators of schizophrenia, such as birth complications or cerebral ventricular enlargement, based on different aetiological models are the high-risk method, the family study method, and the familial-sporadic strategy (Lewis et al 1987). In the latter, patients are divided into familial cases who have a positive family history of schizophrenia or schizophrenia spectrum disorders, and sporadic cases, who have no family history of schizophrenia spectrum disorders (Lewis et al 1987).
Aetiological models of schizophrenia fall into two broad categories: unitary models and discrete subtype models. Unitary models can further be divided into multifactorial and latent trait models. Multifactorial unitary models assume that schizophrenia is a multifactorial disorder determined by a single set of aetiological factors that initiate the same basic pathogenic processes. Phenotypic heterogeneity reflects quantitative differences along a single continuum of severity. Latent trait models assume a common factor underlying the single disease process, and observed variations in the phenotype are caused by pleiotropy. In contrast, discrete subtype models suggest that schizophrenia can be subdivided into distinct disorders at the level of aetiology or pathophysiology. (Kremen et al 1992)
The multifactorial polygenic model assumes that liability to schizophrenia is composed of genetic and environmental risk factors that act in an additive fashion. If we are studying an indicator that is thought to be environmental, for example birth complications, the model suggests that familial probands will manifest less severity on the indicator than sporadic probands, familial probands will manifest greater severity than their relatives with milder schizophrenia spectrum disorders, and unaffected relatives of familial probands will have the lowest severity. If the indicator is thought to reflect genetic liability, the group with the greatest amount of genetic vulnerability will manifest the greatest severity. Thus, familial probands should show greater severity on the indicator than sporadic probands, relatives with schizophrenia spectrum disorders should show less severity than familial probands but greater severity than the unaffected relatives of familial probands, and unaffected relatives of familial probands should show greater severity on the indicator than the unaffected relatives of sporadic probands. (Kremen et al 1992)
The latent trait model is a single major locus model in which the pathogenic gene can cause schizophrenia, or increased severity on the indicator, or both. The indicator is a marker of the presence of the same genotype as the disorder itself. A strict single-gene model has been proposed by Crow, who suggests that one human gene, that causing cerebral asymmetry, contributes substantially to the predisposition to psychosis (Crow 1995, 1995a). This gene, according to Crow, is crucial to the development of language and is associated with significant variation, which explains the variation in the phenotype (Crow 1995a). The model excludes any environmental risk factors (Crow et al 1995a). The model by Crow, although elegant, is not supported by the majority of research findings (Tsuang & Faraone 1995, DeLisi 1999).
Kremen et al (1992) modified the latent trait model by suggesting that sporadic probands are phenocopies and do not, therefore, have the genotype that produces the indicator. This modified model predicts that familial probands will manifest greater indicator severity than sporadic probands, unaffected relatives of familial probands will show greater severity on the indicator than unaffected relatives of sporadic probands, and relatives with schizophrenia spectrum disorders will manifest equal indicator severity to the familial probands themselves (Kremen et al 1992).
The interactive model suggests that some combination of pathogenic genes and environmental risk factors is necessary for schizophrenia to develop. One variant of the model is a multifactorial version, which suggests that if a threshold number of genes with small additive effects is not passed, no amount of environmental liability is sufficient for schizophrenia to develop. Another variant assumes that there is a single pathogenic gene which alone causes mild schizophrenia spectrum disorder, and schizophrenia develops only with enough additional environmental liability. Both of the models predict the same findings. If it is assumed that the indicator is environmentally caused, the familial probands will manifest the greatest severity on the indicator, relatives of familial probands with schizophrenia spectrum disorders will manifest the least indicator severity, and unaffected relatives of familial probands will show intermediate indicator severity. The model does not allow for genetic differences between familial and sporadic probands and no specific predictions can be made with respect to sporadic probands. (Kremen et al 1992)
The discrete subtype model assumes that schizophrenia may be caused by either genetic or environmental factors. If the indicator reflects some alternate, nongenetic cause of schizophrenia, the model predicts that sporadic probands will manifest greater severity on the indicator than familial probands, and no differences with respect to the indicator among any of the groups of relatives because none of them has been subject to the environmental factor associated with the indicator. (Kremen et al 1992)
There is also the possibility that the indicator is caused by the underlying pathophysiological process of schizophrenia, in which case there should be no difference in the severity of the indicator between familial and sporadic probands, schizophrenia spectrum relatives of familial probands should show intermediate severity of the indicator between probands and unaffected relatives, and unaffected relatives of both familial and sporadic probands should manifest minimal severity. If the indicator is a result of being treated, only those probands, whether familial or sporadic, who have been treated will have the indicator. (Kremen et al 1992)
How do findings from studies conducted thus far fit into these models? It seems likely that none of the models will fit all cases with schizophrenia. For example, some rare cases of schizophrenia seem to be caused by gross abnormalities in chromosomes (Tsuang & Faraone 1995). Several different models are supported by the research. Cerebral ventricular enlargement has been shown to be more prevalent among sporadic than familial cases, especially among males (DeQuadro et al 1996, Murray & Jones 1995), supporting, in the absence of information on relatives, both the multifactorial polygenic model with an environmental indicator and the discrete subtypes model. The Copenhagen high-risk study found greater ventricular enlargement in high-risk subjects with schizophrenia than high-risk and low-risk subjects with schizophrenia spectrum disorders or no disorder (Cannon et al 1994). However, they also observed that among the high-risk subjects, those who later developed schizophrenia experienced the greatest number of obstetric complications, while those who later developed schizophrenia spectrum disorders experienced the least, supporting the interactive model in the effect of obstetric complications (Parnas et al 1982). In the determination of ventricular enlargement, they found a linear increase in cerebral ventricles with increasing level of genetic risk for schizophrenia, and an interaction between obstetric complications and genetic risk: the effect of obstetric complications was largest among persons with two affected parents (Cannon et al 1993a).
Different aetiological models may thus account for different aspects of the disorder, and the extreme homogeneity model, which assumes that schizophrenia is caused by exactly the same pattern of genetic and environmental factors, can be rejected (Tsuang & Faraone 1995). Gottesman and Shields proposed a combined model, in which the majority of cases would be caused by the combined effect of genetic and environmental factors (Gottesman & Shields 1982, pp. 220-222). The genetic effect would mostly be polygenic, but there might also be cases caused by a single major gene plus polygenic background. Besides these cases, there would be rare cases caused by single rare genes or chromosomal abnormalities, and rare phenocopies caused entirely by environmental factors (Gottesman & Shields 1982, pp. 220-222). This kind of model, which lets many flowers blossom, would seem wise until proved otherwise.
Schizophrenia is a global disorder, but there is controversy over whether it also occurs at similar frequency worldwide (Torrey 1989). The peak age at onset is early adulthood (Sham et al 1994). It tends to occur more frequently - or at least at an earlier age - among males than females (Castle et al 1995). Recent studies have suggested that the incidence of schizophrenia is declining (Munk-Jørgensen 1995). These studies have divided the opinion of researchers: some regard the findings as unreliable, caused entirely by the operation of confounding factors such as narrowing diagnostic criteria, while others believe that a genuine decline in the incidence has occurred (Geddes et al 1993, Kendell et al 1993, Harrison & Mason 1993, Munk-Jørgensen 1995). If the decline is genuine, new information on the risk or protective factors of schizophrenia may be gained by investigating what was happening when the incidence declined, or when the cohorts whose incidence declined were born.
Both genetic and environmental factors have been shown to be important in the aetiology of schizophrenia. Although the heritability of schizophrenia in different populations has been high, no genes predisposing to schizophrenia have so far been identified. Obstetric complications are the best supported environmental risk factor for schizophrenia, but they are probably not themselves sufficient to cause it (Geddes et al 1995). Infections may also be involved in the aetiology of schizophrenia (Yolken & Torrey 1995). Patients with schizophrenia have a seasonal variation of births that differs from that of the general population (Torrey et al 1997), and persons born in urban areas with high population density seem to have an increased risk of developing schizophrenia (Mortensen et al 1999). The cause of both these phenomena is unknown, but environmental risk factors has been suggested.
In Finland, many aspects of the epidemiology of schizophrenia have not been previously studied; these include possible changes in incidence, and seasonal variation of births in schizophrenia. However, we have a long tradition of aetiologic research on schizophrenia (Alanen et al 1966, Mednick et al 1988, Tienari et al 1994), and research on the genetic epidemiology of schizophrenia has advanced in recent years (Hovatta et al 1997, Cannon et al 1998). Finland's stable, relatively isolated population and excellent health-care registers are unique assets for epidemiologic research. Thus, this study was set out to investigate epidemiological features and some risk factors of schizophrenia in the Finnish population. The study focused on changes in the incidence of schizophrenia, time trends in the seasonal variation of births in schizophrenia, the association between prenatal exposure to poliomyelitis epidemics and later development of schizophrenia, and the association between familial loading for psychotic disorders and age at onset and outcome of schizophrenia.